Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Open accessThe DOI matches its Crossref record; 1,697 of the 1,707 references it cites were found in a registry or an index; 319 of the 451 sources its claims cite were checked for support.
Abstract
The third edition of Flow Cytometry Guidelines provides the key aspects to consider when performing flow cytometry experiments and includes comprehensive sections describing phenotypes and functional assays of all major human and murine immune cell subsets. Notably, the Guidelines contain helpful tables highlighting phenotypes and key differences between human and murine cells. Another useful feature of this edition is the flow cytometry analysis of clinical samples with examples of flow cytometry applications in the context of autoimmune diseases, cancers as well as acute and chronic infectious diseases. Furthermore, there are sections detailing tips, tricks and pitfalls to avoid. All sections are written and peer‐reviewed by leading flow cytometry experts and immunologists, making this edition an essential and state‐of‐the‐art handbook for basic and clinical researchers.
Overview
CoChat Summary
TL;DR
This third edition of the Flow Cytometry Guidelines is a peer-reviewed handbook for flow cytometry and cell sorting in immunological studies, covering phenotypes and functional assays of major human and murine immune cell subsets, clinical applications, and practical controls. It emphasizes reproducibility, essential controls, panel design, rare-event detection, and human-mouse differences, with protocols, gating strategies, and pitfalls.
Key findings
- The Guidelines provide comprehensive sections on phenotypes and functional assays of major human and murine immune cell subsets, with tables highlighting phenotypes and key differences between human and murine cells, plus clinical applications in autoimmune diseases, cancers, and acute/chronic infections.
- On reproducibility, the text cites a 2012 study reporting that 47 of 53 published findings could not be replicated, and states that 77–90% of biomedical experiments are not reproducible; inter-laboratory variation is reported as ~20% CV versus ~4% in a central laboratory.
- For rare cells, “rare” generally refers to events with a frequency of 0.01% or less, with a literature record of one cell in 10 million for tumor cells spiked in peripheral blood; Poisson statistics examples show 5,000 events give a CV of 4.24 and 10,000 events give a CV of 3.16 for a 10% positive population.
- High-dimensional panel design guidance notes that latest-generation instruments can measure up to 28 fluorescent parameters, spectral cytometry has reportedly been used for up to 40 parameters, and 50 or more may be possible; the spillover spreading matrix is recommended to manage spreading error.
Methods
- This is a consensus/guideline document, third edition, written and peer-reviewed by leading flow cytometry experts and immunologists; content is organized by cell type, with human sections followed by murine sections, and includes functional assays, pitfalls, top tricks, and clinical relevance statements.
- It presents step-by-step protocols, antibody panels, buffers, gating strategies, and data analysis examples for human and murine immune subsets, rare cells, tissue-resident T cells, regulatory T cells, and other populations, including examples from clinical samples.
- The main approach is recommendations for essential controls (setup/instrument, specificity/gating, biological), reproducibility and quality management, MIFlowCyt compliance and data display, panel design using the spillover spreading matrix, rare-event acquisition, and computational data analysis.
Limitations
- The paper states that the third edition omits advanced flow cytometry techniques featured in the second version and does not include the classical chapters “Principles of flow cytometry” and “Cell sorting”; the introductory chapter is significantly reduced compared with previous editions.
- The text notes that many minimal-information standards are under construction, that no consensus exists for markers or pre-analytical enrichment for some rare populations such as circulating endothelial cells and their progenitors, and that FMO controls cannot account for unspecific binding; some markers are affected by cryopreservation or enzymatic digestion.
- Evident from the text: as a guidelines/consensus handbook, it is not a systematic review or a primary hypothesis-testing study, and its recommendations may require local validation and titration.
Model-written summary of a shortened version of the paper’s full text (it is longer than we read). Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1. Uni-, bi- and multi-parameter and incorrect presentation of flow data. Comparison of two gender and age matched patients: a healthy one (67 years) and a patient with B-CLL (64 years). (A) 1D-histogram presentation of CD3 expression on lymphocytes (red: B-CLL, grey: healthy), (B) 2D-dot-plot presentation of CD3 expression on x-axis vs. CD16/56 expression on y-axis, (C) multivariate presentation of expression of 13 different Abs on 10 colors (OMIP-023 [50]) for nine different leukocyte subsets in a radar-plot. Abbreviations used: B-CLL (B cell chronic lymphocytic leukemia), Th (CD4+ T-helper cell), Tc (CD8+ cytotoxic T cell), NK (natural killer cell). (D) Incorrect and correct data presentation example (Data analysis: (A and B) FlowJo, V10.2; (C) Kaluza, Beckman-Coulter, V 1.1, (D) FCS Express V.6, De Novo Software).](https://figures.cochat.ai/paper-figures/8dd3577b03e54a27aac5059222cd3416/guidelines-for-the-use-of-flow-cytometry-and-cell-sorting-in-immunological-figure-1.jpg)
![Figure 2. Semi-automated clustering and analysis of flow cytometric data by SPADE [32] and hierarchical clustering. (A) SPADE tree display and CD3 expression on blood cells from two male patients. Dot-plot analysis reveals groups of clusters (circles) belonging to the same cell type. (B) Color codes correlate with expression level from low (blue) to high (red) and size of the nodes correlate with cell frequencies (see also scale bar). Data of A and B are from a healthy (B1 and 3; 67 years) and a B-CLL patient (B.2 and 4; 64 years). (C) Hierarchical clustering of flow-cytometry data to visualize and distinguish immune response of pediatric patients (columns) who underwent elective cardiovascular surgery with (left of the yellow line) or without synthetic steroid administration (right) before surgery. PBL was immunophenotyped at day 1 after surgery. Flow cytometry parameters (MFI (mean fluorescence intensity) and cell counts) are displayed horizontally. Red indicates relative upregulation and green relative down-regulation of the respective parameter (see also scale bar). (Data and legend from [57]; reproduction with permission.) (SPADE analysis by Cytoscape, V 3.4.0, Nolan Lab; hierarchical clustering by free software Genes@Work).](https://figures.cochat.ai/paper-figures/27b18b1d19c54e1ab0b45ddd99e443dd/guidelines-for-the-use-of-flow-cytometry-and-cell-sorting-in-immunological-figure-2.jpg)
![Figure 3. Semi-automated analysis of flow cytometry data by tSNE. (A) Sixteen-part differential of 10 individuals (5 smokers, 5 non-smokers) by OMIP-23 (10 colors, 13 Abs; [50]) showing the location of regular T-helper (Th) and cytotoxic T cells (Tc) with high side scatter (Th hiSSC, Tc hiSSC), T-regulatory cells (Treg), natural killer (NK) and NK-T cells on the tSNE map. Bottom center box contains information for calculating the tSNE plot. The image on the right shows the same figure in a inverted way with less red-green compound and better distinguishable for individuals with Deuteranomaly. (B) Heat map display of expression level of 5 activation markers in non-smokers and smokers and distribution of cell count (All). Scale bars right of each tSNE plot show color coding of fluorescence intensity or cell count levels. (Data of individuals from the LIFE study [58]; data analysis by FCS Express V.6, De Novo Software. Exemplary data and gating examples can be found in the supplementary materials and FlowRepository link of reference [50]).](https://figures.cochat.ai/paper-figures/3c000c6335b94742822835a32085a5a6/guidelines-for-the-use-of-flow-cytometry-and-cell-sorting-in-immunological-figure-3.jpg)









































![Figure 45. Flow cytometric analysis of IL-10 production by human CD4+ T-cell subsets. (A) Conventional human CD4+ T-cells (Complete gating strategy see Chapter human CD4+T-cells) were isolated according to IL-7R and CCR6 expression and stimulated for 4 or 30 hours with anti-CD3 Abs in the absence or presence of anti-CD28 Abs or 100 U/ml IL-2. The production of IL-2 and IL-10 is shown. The frequencies of IL-10+ cells are reported (Statistics: paired student’s t-test, n=5). (B and C) Representative intracellular IL-10 and IFN-γ stainings of FACS-purified CD4+CXCR5+ICOS+ tonsillar TFH-cells (B) or of human blood CD4+IL-7RlowCD25−T-cells (C) stimulated with PMA and Ionomycin for 4 h. (D) Same as in C, but IL- 10 was analyzed with a secretion assay and combined with CD40L surface staining. (E) IL-10 secretion of human CD4+T-cells following overnight stimulation of total PBMC with SEB gated on CD4+LAG3+CD49b+Tr1- cells. 2010 Häringer et al. Originally published in J. Exp. Med. https://doi.org/10.1084/jem.20091021 [163] (Fig. 45A) and https://doi.org/10.1084/jem.20082238 [165] (Fig. 45C).](https://figures.cochat.ai/paper-figures/46a2165cae394e23b082974260772a3a/guidelines-for-the-use-of-flow-cytometry-and-cell-sorting-in-immunological-figure-45.jpg)









![Figure 55. Identifying human naïve and effector sub-groups of adaptive Vγ9−/Vδ2+ and Vδ2− γδ T cells in the circulation. After application of the gating strategy described in Figure 53, the distribution of clonally diverse naïve human γδ T cells can be identified by the expression of CD27 and CD45RA (CD27hi; marked in red) and clonally expanded effector γδ T cells (CD27lo; marked in blue), see Davey et al. [531]. These naïve and effector subsets display very distinct phenotypes and can be further defined by the expression of CX3CR1, Granzyme A/B or IL7Rα. The data shown here is an example of the expression of these markers in human Vδ1+ γδ T cells.](https://figures.cochat.ai/paper-figures/ef6e32814de84dfc902a5e420c8671e1/guidelines-for-the-use-of-flow-cytometry-and-cell-sorting-in-immunological-figure-55.jpg)

















![Figure 73. Enrichment of human Ag-specific T-cells increases sensitivity for the detection of rare cells. (A) CD154 and TNF-α expression was analyzed on human CD4+ T-cells without addition of an Ag and following stimulation with the neo-Ag keyhole limpet hemocyanin (KLH). Cells are gated on CD4+ T-cells and percentage and absolute numbers of CD154+ cells after acquiring 5x10e5 PBMCs (upper plots) or obtained from 1×10e8 PBMCs after enrichment of CD154+ cells (lower plots). (B) Phenotypic characterization of the enriched CD154+CD4+ T-cells to discriminated between CD45RO+ memory cells and CD45RO-CCR7+ naive T-cells, following stimulation with a peptide pool of C. albicans MP65 as recall Ag or KLH as neoantigen. (C) Parallel detection of Ag-specific Tconvs (CD154+) and Tregs (CD137+) following stimulation with birch pollen lysate and magnetic enrichment for CD154+ and CD137+ cells from 2x10e7 stimulated PBMC. Upper plots: cells are gated on CD4+ T-cells and absolute cell counts of CD154+ and CD137+ cells with and without stimulation are indicated. Lower plots: Overlayed flow-cytometric analysis of birch-specific CD154+ and CD137+ cells. Numbers indicate percentages among CD137+CD154-CD4+ T-cells and absolute numbers of CD137+CD25+FOXP3+ Treg. (D) To describe the precision of flow cytometry data, the coefficient of variance (CV) can be calculated from the variance and the standard deviation (SD). For rare cell analysis, the approximations SD = √r and CV [%] = 100/√r can be used, where r is the number of positive events (53). From CV [%] = 100/√r follows r = [100/CV]2. Using this approximation, the number of total required events is illustrated depending on the frequency of target cells for different CVs.](https://figures.cochat.ai/paper-figures/4d6942695ed24e25a27c0dcbabd88552/guidelines-for-the-use-of-flow-cytometry-and-cell-sorting-in-immunological-figure-73.jpg)

![Figure 75. Representative gating strategy used to identify human SARS-CoV-2-specific CD8 T cell responses. Data used in this figure is from [776], which is licensed under CC BY 4.0. Step 1: Gating strategy used to identify single and live CD8+ cells. Step 2: Gating strategy used to identify pMHC+ CD8+ cells required for the Boolean gating. Step 3: Representative overview of all 75 pMHC dual color code combinations after Boolean gating. Antigen-specific CD8 T cells (double-positive pMHC+ CD8+ cells) are shown in green and bulk CD8 T cells (pMHC− CD8+ cells) in grey. Percentage of Ag-specific CD8 T cells of total CD8 T cells is indicated if applicable.](https://figures.cochat.ai/paper-figures/4652ebfda4a445ce9c8beba74e715c37/guidelines-for-the-use-of-flow-cytometry-and-cell-sorting-in-immunological-figure-75.jpg)
![Figure 76. Production and usage of pMHC multimers (Originally published in The Journal of Immunology [790]). (A) pMHC monomer generation through folding and functionalization; (B) Epitope exchange technologies enable high-throughput generation of pMHC complexes for different Ag-specificities; (C) Different usage of nonreversible, reversible, and dye-conjugated reversible pMHC multimers; (D) The steric structure of multimers in a three dimensional space forms tetrahedron like structures limiting the binding layer to three pMHC molecules at once.](https://figures.cochat.ai/paper-figures/c2361054fc284bfb9d9994e13067b4c7/guidelines-for-the-use-of-flow-cytometry-and-cell-sorting-in-immunological-figure-76.jpg)
















![Figure 93. TDS assay for analysis of human blood CD8 T cells. (A) Gating strategy. Example of viable single CD8 T cell gating in 6 steps: 1) Single cells. Single cells having 2n≤ DNA content ≤4n were selected on the DNA-Area (A) versus (vs) DNA-Width (W) plot; 2) Time. Stable acquisition over time (seconds) was monitored on the time vs DNA-A plot and any events collected in case of pressure fluctuations were excluded; 3) Live cells, no “dump”. CD4+, CD14+, CD19+ cells were excluded on the “dump” channel, and live cells selected using the L/D eF780 dye; 4) “relaxed” FSC/SSC gate. A “relaxed” gate was used on the FSC-A vs SSC-A plot, to include highly activated and cycling lymphocytes [877, 878]; 5) CD8 T cells. CD8 T cells were gated on the CD3 vs CD8 plot. 6) No “shadow” doublets. A few remaining doublets composed by one cell sitting on top of another (so called “shadow” doublets) were excluded as Ki-67int/− events having > 2n DNA content [878]. Numbers indicate cell percentages in the corresponding gate. This gating strategy was used as a base for CD8 T cell analysis. EBV-specific CD8 T cells in Infectious Mononucleosis (B) and Asymptomatic EBV-Carrier (C). Example of CD8/ EBV-tetr plot showing EBV-tetr+ cell gate (top left) and tetr FMO control (bottom left). Cell cycle phases of EBV-tetr+ cells were defined on DNA-A vs Ki-67 plot as follows (top center): cells in G0 were identified as DNA 2n/ Ki67− (bottom left quadrant); cells in G1 as DNA 2n/ Ki-67+ (upper left quadrant); cells in S-G2/M as DNA>2n/ Ki-67+ (TDS cells, top right quadrant). Ki-67 FMO controls are shown (bottom center). Note that the “No shadow doublet” gate (Step 6 in A) cannot be applied to Ki-67 FMO samples. FSC-A/-SSC-A plot (top right), showing TDS cells (in red) overlaid on total EBV-tetr+ cells (in grey). Gating strategy and mAb panel indicated in A. Unpublished data in relation to [878]. Naïve/memory CD8 T cells in COVID-19 patients (D) and Healthy donors (E). The following naïve/memory subsets of CD8 T cells were identified in the CCR7 vs CD45RA plot (left): CD45RA+ CCR7+ naïve, CD45RA− CCR7+ (CM), CD45RA− CCR7− (EM), and CD45RA+ CCR7− TEMRA. Cell cycle phases of each subset were analyzed as in B and C (right). Gating strategy and mAb panel as in A, except for using CD4 BV711 only in “dump” channel (step 3), and CD3 FITC and CD8 PerCp-Cy5.5 (step 5). Unpublished data in relation to [880].](https://figures.cochat.ai/paper-figures/1b22218da0714f20b08f77b9d9fe8339/guidelines-for-the-use-of-flow-cytometry-and-cell-sorting-in-immunological-figure-93.jpg)
![Figure 94. TDS assay for analysis of mouse blood CD8 T cells. BALB/c mice were vaccinated against HIV-1 gag used as a model Ag by prime with ChAd3-gag and boost with MVA-gag, as described [877]. TDS assay was performed on blood collected at day 3 and day 44 after boost. Blood from 3 mice was pooled to obtain enough cells for analysis. (A) Gating strategy. Example of gating of viable single CD8 T cells in 6 steps: 1) Single cells. Single cells having 2n≤ DNA content ≤4n were selected on the DNA-Area (A) versus (vs) DNA-Width (W) plot; 2) Time. Stable acquisition over time (seconds) was monitored on the time vs DNA-A plot and any events collected in case of pressure fluctuations were excluded; 3) Live cells. Live cells were selected on the FSC-A vs L/D eF780 plot; 4) “relaxed” FSC/SSC gate. A “relaxed” gate was used on the FSC-A vs SSC-A plot, to include highly activated and cycling lymphocytes [877]; 5) CD8 T cells. CD8 T cells were gated on the CD3 vs CD8 plot. 6) No “shadow” doublets. A few remaining doublets composed by one cell sitting on top of another (so called “shadow” doublets) were excluded as Ki-67int/− events having > 2n DNA content [878]. Numbers indicate cell percentages in the corresponding gate. This gating strategy was used as a base for CD8 T cell analysis. (B) gag-specific CD8 T cell frequency at day 3 and day 44 post-boost. Example of gag-tetr/ gag-pent plots, showing “gag-specific” and “not gag-specific” cell gates in untreated (left) and vaccinated (right) mice at day 3 (top) and day 44 (bottom) post-boost, as indicated. (C) Cell cycle of gag-specific and not gag-specific CD8 T cells from vaccinated mice at day 3 and day 44 post-boost. Cell cycle phases of “gag-specific” (left) and “not gag-specific” (right) cells from vaccinated mice at day 3 (top) and day 44 (bottom) post-boost were defined on DNA-A vs Ki-67 plot as follows: cells in G0 were identified as DNA 2n/ Ki-67− (bottom left quadrant); cells in G1 as DNA 2n/ Ki-67+ (upper left quadrant); cells in S-G2/M as DNA>2n/ Ki-67+ (TDS cells, top right quadrant). Ki-67 FMO controls are shown. Note that the “No shadow doublet” gate (Step 6 in A) cannot be applied to Ki-67 FMO samples. Unpublished data in relation to [877].](https://figures.cochat.ai/paper-figures/91991fd3b2ab43369d0ab165b5e4ba1b/guidelines-for-the-use-of-flow-cytometry-and-cell-sorting-in-immunological-figure-94.jpg)














![Figure 109. Representative gating strategy and analysis of human peripheral blood PB/PC in a patient with active systemic lupus erythematosus (SLE). Patients with flaring SLE show increased numbers and frequencies of peripheral blood PB/PC [942, 1088]. We thus chose an SLE blood sample for illustration, containing approx. 15% PB/PC among total B cells. Note that in steady-state, i. e. in the absence of in intentional immune activation or symptomatic disease, PB/PC are found at frequencies of commonly approx. 1% among total B cells. (A) Gating strategy. Data were analyzed for changes of scatter or fluorescence parameters over the time of data acquisition, and optionally gated to remove parts of the acquisition that show irregular or discontinuous cytometric patterns. Then, a large light scatter parameter gate was used to identify lymphocytes and monocytes. FSChigh cells represent doublets and were excluded. SSChigh cells correspond to remaining granulocytes, likely low density granulocytes described before in SLE [1102] that were co-enriched along with PBMC. Next, cell aggregates were removed by gating on cells showing closely correlating area and height values of the FSC signal. Most cell doublets are characterized by a relatively increased FSC-area vs. FSC-height ratio. Live B cells were detected by staining for CD19, and exclusion of T cells, monocytes and dead cells according to CD3, CD14, and DAPI staining. Note that the B cell gate captures CD19dim cells, which can be strongly enriched for PB/PC. CD19 expression itself is subject to regulation in e. g. autoimmune conditions [1103, 1104], so that boundaries of the B cell gate should be carefully validated. CD19+CD3−CD14−DAPI− B cells were then analyzed for CD20 and CD27 expression, revealing CD20+ subsets of naive and memory B cells besides PB/PC with a CD27highCD20low/− phenotype. In this (SLE) sample, PB/PC are detectable at increased frequencies; normal donors show commonly less than 2% PB/PC among CD19+ B cells. (B) PB/PC were then analyzed for expression of CD38 and CD138. Virtually all CD27highCD20low/− gated PB/PC expressed high levels of CD38, and two thirds expressed CD138. T cells and monocytes not expressing CD138 and containing very few CD38high cells are shown for comparison. (C) As an alternative to the PB/PC gating shown in (A-B), total PB/PC, or CD138+ PB/PC can be gated in various combinations of the markers CD20, CD38, CD27 and CD138, with consistent results. (D) PB/PC show a unique FSC and SSC profile distinct from that of total lymphocytes, B lymphocytes, and monocytes. (E) Backgating confirms the validity of the gating strategy. In particular, it shows that the entire PB/PC subsets was included during light scatter gating, some PB/PC events were excluded as doublets, and that significant amounts of T cells and/or monocytes share the CD27highCD20−/low phenotype of PB/PC and may contaminate this population unless careful CD19 gating and DUMP channel exclusion is employed.](https://figures.cochat.ai/paper-figures/12c073c705d84e648e87020c17b57aa8/guidelines-for-the-use-of-flow-cytometry-and-cell-sorting-in-immunological-figure-109.jpg)

![Figure 111. Representative gating strategy and analysis of human bone marrow PC. (A) Analytical gating strategy. Time/CD45 visualization confirms the stability of the cytometric measurement over time. Time frames showing discontinuous data were excluded if applicable. As PC exhibit particular light scatter and background fluorescence properties, the CD138+CD38high PC population was gated first, followed by cell aggregate exclusion and gating on CD3−, CD16−, CD10−, CD14− and DAPI− cells for exclusion of dead cells and potentially contaminating cell types. Then, the FSC-A/SSC-A plot reveals that PC show a broader light scatter signal distribution compared to other lymphocytes due to their increased size and ellipsoidal shape. Should the FSC-A/SSC-A plot reveal remaining FSClow and/or SSClow cell debris or electronic artifacts, these should be excluded by gating at this step. (B) Human BM PC consistently display distinct populations with either high or low to no expression of CD19 [901, 1105]. The absence of HLA-DR expression confirms at large the absence of PB [941, 1084], and remaining HLA-DR+ PB are excluded. (C) Backgating analyses of the procedure shown in (A). (D) Comparison of Ab staining and light scatter properties of total CD138+CD38+ BM PC vs total BM mononuclear cells. PC exhibit increased background fluorescence signals compared to other cells (possibly integrating cell size effects, autofluorescence, and non-specific binding of labeled Abs) stressing that gating should be adjusted at the level of PC rather than at global levels. Consistent with their increased size, non-spherical shape, and high organelle content, BM PC show a FSC / SSC pattern distinct from that of other BM cells.](https://figures.cochat.ai/paper-figures/7beaeaedcb0546d59c3b2d229e2ff2f3/guidelines-for-the-use-of-flow-cytometry-and-cell-sorting-in-immunological-figure-111.jpg)
![Figure 112. Detection of human peripheral blood PB/PC in a high-dimensional mass cytometry dataset of peripheral blood leukocytes. Data represent leukocytes of a pool of ten cryopreserved whole blood samples. Samples were thawed and RBC were lysed. Leukocytes underwent barcoding, were pooled and stained with cocktail of isotope-conjugated Abs including the markers depicted, and acquired on a Helios mass cytometer (Fluidigm). Detailed information is provided in the publication of the full dataset [1101]. After curation, data of up to 200.000 cells from each sample were subjected to opt-SNE (plotted: 1.937 x 106 cells). (A) Major cell populations and CD38high PB/PC were gated according to their characteristic marker expression profile in the tSNE dimensions and mapped to the t-SNE plot. Note that PB/PC form distinct and condensed subpopulations. (B) Expression of major leukocyte lineage markers and CD38. (C) Gated PB/PC (1697 cells) were subjected to a second opt-SNE run, revealing subsets of IgA+ and IgA− PB/PC, and differential expression of HLA-DR.](https://figures.cochat.ai/paper-figures/c5c2de9039b248ad83667f4d8c0b6789/guidelines-for-the-use-of-flow-cytometry-and-cell-sorting-in-immunological-figure-112.jpg)








![Figure 121. Identification of murine SI LP ILCs. Representative gating strategy of ILCs derived from the SI LP of 6-week-old C57BL/6 mice. Mononuclear cells (MCs) were prepared as previously described [1294]. Cells were gated as viable (LD, eF780−), B220(APC-Vio770)− CD11c(APC-Cy7)− Gr-1(APC-Fire780)− F4/80(APC-Fire780)− Fc√R1α(APC-Cy7)− (Lin−) CD45+ TCRβ− TCRγδ− and either as NKp46+ (grey gate, A) T-bet+ Eomes− ILC1, Eomes+ T-bet+ NK cells or as CD127+ (black gate, B) GATA3+ RORγt− ILC2 and RORγt+ GATA3lo ILC3 which can be further separated according to NKp46 and CD4 expression (B). Gate numbers reflect population frequencies.](https://figures.cochat.ai/paper-figures/ef054c47472e46e1a5969718f5fdf218/guidelines-for-the-use-of-flow-cytometry-and-cell-sorting-in-immunological-figure-121.jpg)














![Figure 136. Gating of human umbilical cord blood neutrophils. Flow cytometric analysis of human umbilical cord blood neutrophil subsets. Doublets and dead cells are first excluded, followed by the exclusion of CD45− cells. Lineage cells and monocytes are excluded before total granulocytes are gated with CD15 and CD66b. From there, eosinophils are excluded before gating on the classical nomenclature of neutrophil subsets using CD11b and CD16. P_M = Promyelocytes and Myelocytes, MM = Meta-myelocytes, BN = Band cells, SN = Segmented neutrophils. Gating is adapted from [1469, 1480].](https://figures.cochat.ai/paper-figures/afe12f9e6b7b48dc9ce988da718c300f/guidelines-for-the-use-of-flow-cytometry-and-cell-sorting-in-immunological-figure-136.jpg)
![Figure 137. Alternative gating strategy to classical nomenclature for identifying human neutrophils. An alternative to using CD11b vs CD16 (Figure 136, panel 10), total human cord blood neutrophils can be divided into CD11b− neutrophil progenitors and CD11b+ neutrophils [1479, 1481]. The proliferative CD11b+ preNeus can be separated using CD101 and CD49d as shown previously [1478]. The remaining non-proliferative pool of neutrophils can be separated with CD10 as described previously [1482].](https://figures.cochat.ai/paper-figures/1390502788b04c69969e342f15769d61/guidelines-for-the-use-of-flow-cytometry-and-cell-sorting-in-immunological-figure-137.jpg)



![Figure 141. Phenotypic characterization of HSCs from CD34-enriched human cord blood. HSPCs were identified as CD34+ CD38− cells within the human CD45+ Lin− compartment. The lineage cocktail contained the following Abs: CD3, CD10, CD14, CD15, CD16, CD19, and CD235. HSCs were identified as CD34+ CD38− CD90+ CD45RA− cells and MPPs as CD34+ CD38− CD90− CD45RA− cells [1551]. LT-HSCs with increased expansion potential can be identified within cells expressing the top 20% of Kit [1553], and LT-HSCs containing the highest repopulating activity express high levels of CD49f [1553]. Gatings for CD38 and CD90 were set according to isotype controls. Gating strategies for Kit and CD49f are chosen according to the original publications [1552, 1553]](https://figures.cochat.ai/paper-figures/a197a027490d43f795e25894ed6582c2/guidelines-for-the-use-of-flow-cytometry-and-cell-sorting-in-immunological-figure-141.jpg)











Verification
Claims the paper makes
190 Valid · 30 Not valid · 55 Not checked · 112 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Several studies have compared different anti-human FOXP3 Ab clones, and although there is some debate, there is a general consensus that the 236A/E7 and 259D clones are optimal [394-398].”
§ Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) > T cell phenotypes > Human FOXP3+ regulatory T cells
What the sources say
- Partly supportedcites [394] Fox BC, Bignone PA, Brown PJ and Banham AH, Defense of the clone: antibody 259D effectively labels human FOXP3 in a variety of applications. Blood 2008. 111: 3897– 3899. 18362214 sourceExperimental — accuracy not yet measured
The comparison and Figure 1 caption (p. 2) support 259D/C7 as an effective FOXP3 detector and acknowledge debate about antibody sensitivity. They do not establish a general consensus that both 259D and 236A/E7 are optimal; the Figure 1 caption reports weaker Western-blot labeling with 236A/E7 than with 259D/C7 and 206D/B1. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [395] Kaur G, Goodall CJ, Jarvis LB and Gaston Hill JS, Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells–identification of Foxp3Delta7 in human regulatory T cells. Mol. Immunol 2010. 48: 321– 332. 20688398 source
- Partly supportedcites [396] Law JP, Hirschkorn DF, Owen RE, Biswas HH, Norris PJ and Lanteri MC, The importance of Foxp3 antibody and fixation/permeabilization buffer combinations in identifying CD4+CD25+Foxp3+ regulatory T cells. Cytometry A 2009. 75: 1040– 1050. 19845018 PMC2862733 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) identifies 259D/C7 and 236A/E7 among four clones that yielded the most distinct putative regulatory T-cell populations. It does not establish a general consensus that those two alone are optimal; it also names PCH101 and 206D, and reports that staining depends on the buffer and fluorochrome used. (LLM, conf=0.86)
- Could not verifycites [397] Mahnke YD, Beddall MH and Roederer M, OMIP-015: human regulatory and activated T-cells without intracellular staining. Cytometry A 2013. 83: 179– 181. 23166007 sourceExperimental — accuracy not yet measured
The Background says this panel avoids intracellular FoxP3 staining, and the reagent table lists no FOXP3 antibody. Searches for 236A/E7, 259D, and comparisons of FOXP3 antibody clones found no passage assessing either clone or reporting a consensus that they are optimal. (LLM, conf=0.78)
- Disputedcites [398] Pillai V and Karandikar NJ, Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity. Blood 2008. 111: 463– 464; author reply 464-466. 18156502 PMC2200827 sourceExperimental — accuracy not yet measured
In the letter’s comparison of antibody clones (pp. 463–464), 236A/E7 performs similarly to PCH101 and 206D, but 259D misses FOXP3 expression detected by the other clones. The authors explicitly call 259D an outlier and a less sensitive detector, contrary to describing it as optimal. (LLM, conf=0.93)
Checked by a reasoning model — may be wrong.
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Yet, Helios, Nrp-1 or ROR-γt are widely accepted for the discrimination of tTreg and pTreg cells under homeostatic conditions [364-366, 437-440].”
§ Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) > T cell phenotypes > Murine Foxp3+ regulatory T cells
What the sources say
- Partly supportedcites [364] Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y and Shevach EM, Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol 2010. 184: 3433– 3441. 20181882 PMC3725574 sourceExperimental — accuracy not yet measured
The Discussion (page not provided) says Helios divides peripheral Foxp3+ Treg cells into two populations and suggests that the Helios-negative population is generated in the periphery. But the authors describe that inference as indirect and correlative; this paper does not establish Helios as a widely accepted discriminator under homeostatic conditions. The other markers in the sentence are not the part this Helios study supports. (LLM, conf=0.85)
- Partly supportedcites [365] Weiss JM, Bilate AM, Gobert M, Ding Y, Curotto de Lafaille MA, Parkhurst CN, Xiong H, Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J. Exp. Med 2012. 209: 1723– 1742, S1721. 22966001 PMC3457733 sourceExperimental — accuracy not yet measured
The Results sections report that Nrp1 distinguishes thymus-derived from induced Treg cells in the studied mice and that Helios expression correlates closely, though not perfectly, with Nrp1. The intestinal lamina propria Results mention RORγt+Foxp3+ cells and suggest local induction, but do not establish RORγt as a discriminator of tTreg and pTreg cells or say that all three markers are widely accepted for that purpose under homeostatic conditions. (LLM, conf=0.84)
- Disputedcites [366] Akimova T, Beier UH, Wang L, Levine MH and Hancock WW, Helios expression is a marker of T cell activation and proliferation. PLoS One 2011. 6: e24226. 21918685 PMC3168881 sourceExperimental — accuracy not yet measured
This paper addresses Helios as a proposed discriminator of thymus-derived and peripherally induced Tregs, but its Discussion concludes that Helios is not suitable for distinguishing them. It does not assess Nrp-1 or ROR-γt; the contrary finding concerns the Helios portion attributed to this source. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [437] Sefik E, Geva-Zatorsky N, Oh S, Konnikova L, Zemmour D, McGuire AM, Burzyn D, MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORgamma(+) regulatory T cells. Science 2015. 349: 993– 997. 26272906 PMC4700932 sourceExperimental — accuracy not yet measured
The paper describes Helios and Nrp1 as markers of thymus-derived Tregs and identifies a Helios−RORγ+ population that differentiates locally in the gut (Abstract, page unavailable). But it says the significance of Helios and Nrp1 as origin markers has been questioned, and it does not establish RORγ as a generally accepted marker for distinguishing thymic from peripheral Tregs across homeostatic settings. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [438] Ohnmacht C, Park J-H, Cording S, Wing JB, Atarashi K, Obata Y, Gaboriau-Routhiau V, MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORgammat(+) T cells. Science 2015. 349: 989– 993. 26160380 source
- Partly supportedcites [439] Kim BS, Kim B-S, Lu H, Ichiyama K, Chen X, Zhang Y-B, Mistry NA, Tanaka K, Generation of RORgammat(+) Antigen-Specific T Regulatory 17 Cells from Foxp3(+) Precursors in Autoimmunity. Cell Rep. 2017. 21: 195– 207. 28978473 PMC5716359 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) uses Helios and Nrp-1 to distinguish mostly thymic-derived peripheral RORγt+ Treg cells from intestinal RORγt+ cells of peripheral origin. The Results (page unavailable) say RORγt+ Treg cells occur constitutively in the gut, but the paper also finds RORγt+ cells derived from thymic Treg cells after immunization. It therefore supports the marker-based distinction in these settings, not the broader claim that RORγt itself discriminates tTreg from pTreg cells generally under homeostatic conditions. (LLM, conf=0.82)
- Not checked — no full text of the sourcecites [440] Yang J, Zou M, Pezoldt J, Zhou X & Huehn J, Thymus-derived Foxp3(+) regulatory T cells upregulate RORgammat expression under inflammatory conditions. J. Mol. Med. (Berl) 2018. 96: 1387– 1394. 30357435 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“It is for this reason that the flow cytometry community has defined the minimal amount of data that should be provided to understand and be able to reproduce the data via the MIFlow-Cyt [31] and MiSET RFC Standards [32], more information on which is provided elsewhere in these Guidelines.”
§ Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) > Introduction > Essential controls and reproducibility in flow cytometry
What the sources say
- Supportedcites [31] Lee JA, Spidlen J, Boyce K, Cai J, Crosbie N, Dalphin M, Furlong J, MIFlowCyt: the minimum information about a flow cytometry experiment. Cytometry A 2008. 73: 926– 930. 18752282 PMC2773297 source
The Introduction says MIFlowCyt was developed through a cross-disciplinary process and adopted as an ISAC standard. The Discussion says it specifies the minimum information needed to interpret flow cytometry experiments and understand their conclusions; the Abstract links minimum reporting standards to independent validation. The separate MiSET RFC Standards citation is not attributed to this paper. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [32] Lucas F, Gil-Pulido J, LaMacchia J, Preffer F, Wallace PK and Lopez P, MiSet RFC Standards: defining a universal minimum set of standards required for reproducibility and rigor in research flow cytometry experiments. Cytometry A 2020. 97: 148– 155. 31769204 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation has been followed by a number of additional reports, the summary of which is, in essence, that 77-90% of biomedical experiments are not reproducible [14-17].”
§ Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) > Introduction > Essential controls and reproducibility in flow cytometry
What the sources say
- Partly supportedcites [14] Bradbury A and Plückthun A, Reproducibility: Standardize antibodies used in research. Nature 2015. 518: 27– 29. 25652980 sourceExperimental — accuracy not yet measured
The opening section (page unavailable) reports that a study replicated results from only 6 of 53 landmark preclinical studies—about 89% were not replicated. That supports a figure within the claimed range, but the paper does not give the 77% figure or establish that 77–90% of biomedical experiments generally are not reproducible. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [15] Begley CG and Ioannidis JP, Reproducibility in science: improving the standard for basic and preclinical research. Circ. Res 2015. 116: 116– 126. 25552691 source
- Partly supportedcites [16] Freedman LP, Cockburn IM and Simcoe TS, The economics of reproducibility in preclinical research. PLoS. Biol 2015. 13: e1002165. 26057340 PMC4461318 sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) reports published estimates of irreproducibility ranging from 51% to 89%, so it supports the concern but not the stated 77–90% range. The Analysis of Four Categories of Irreproducibility (page unavailable) gives a 53.3% point estimate for preclinical research, with bounds of 18% to 88.5%; it does not establish that 77–90% of biomedical experiments generally are irreproducible. (LLM, conf=0.87)
- Could not verifycites [17] Fanelli D., Opinion: is science really facing a reproducibility crisis, and do we need it to? Proc. Natl. Acad. Sci. U. S. A 2018. 115: 2628– 2631. 29531051 PMC5856498 sourceExperimental — accuracy not yet measured
The discussion of reproducibility assessments (Frequency of Crisis Narrative in Web of Science Records, p. 3) gives figures for psychology and economics, not biomedical experiments. The medical-literature figure in How Common Are Fabricated, False, Biased, and Irreproducible Findings? (p. 3) concerns false discoveries, not failed replications. Searches for biomedical reproducibility and the 77–90% range found no estimate supporting the claim. (LLM, conf=0.74)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“OMIPs are by nature MIFlowCyt compliant (see as examples: [44, 45, 50, 51].”
§ Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) > Introduction > MIFlowCyt compliance and data display of flow cytometry data in immunological research
What the sources say
- Could not verifycites [44] Dusoswa SA, Verhoeff J and Garcia-Vallejo JJ, OMIP-054: Broad immune phenotyping of innate and adaptive leukocytes in the brain, spleen, and bone marrow of an orthotopic murine glioblastoma model by mass cytometry. Cytometry A 2019. 95: 422– 426. 10.1002/cyto.a.23725. Epub 2019 Jan 31. 30701669 PMC6590190 sourceExperimental — accuracy not yet measured
The ‘Similarity to Other OMIPs’ section (page unavailable) identifies this work as an OMIP and says its optimization and verification data are in FlowRepository. Neither that passage nor the passages returned for searches on MIFlowCyt and reporting standards state that this panel—or OMIPs generally—are MIFlowCyt compliant. (LLM, conf=0.72)
- Could not verifycites [45] Park LM, Lannigan J and Jaimes M C., OMIP-069: forty-color full spectrum flow cytometry panel for deep immunophenotyping of major cell subsets in human peripheral blood. Cytometry A 2020. 97: 1044– 1051. 32830910 PMC8132182 sourceExperimental — accuracy not yet measured
The Abstract identifies this paper as an OMIP panel, but it does not address MIFlowCyt compliance. Searches of our copy for “MIFlowCyt” and minimum-information reporting standards found no passage establishing that OMIPs are compliant by nature. (LLM, conf=0.72)
- Not checked — no full text of the sourcecites [50] Bocsi J, Melzer S, Dähnert I and Tárnok A, OMIP-023: 10-color, 13 antibody panel for in-depth phenotyping of human peripheral blood leukocytes. Cytometry A 2014. 85: 781– 784. 25132115 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
182 more claims · 101 with their cited sources checked
Create a free account to see all 387 claims and every source verdict.
- Probably not a substantial claim. 95
- It may state two separate claims as one. 137
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) > Rare cells-General rules > Number of acquired events
“an Ag that activates less than 0.01% of them”
§ Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) > Rare cells-General rules > Number of acquired events
“namely 100 cells in one million”
Citations
Cites
Items 601–800 of 1,699
KRN7000, a novel immunomodulator, and its antitumor activities.
Kobayashi, E., Motoki, K., Uchida, T., Fukushima, H., & Koezuka, Y. (1995) · PubMed · Cited by 361
From “truly naïve” to “exhausted senescent” T cells: When markers predict functionality
Larbi, A., & Fulop, T. (2014) · Cytometry Part A · doi:10.1002/cyto.a.22351 · Cited by 359
Loeffler, M., Engel, C., Ahnert, P., Alfermann, D., Arelin, K., Baber, R., Beutner, F., Binder, H., Brähler, E., Burkhardt, R., et al. (2015) · BMC Public Health · doi:10.1186/s12889-015-1983-z · Cited by 357
Self-citationTransitional B cells are the target of negative selection in the B cell compartment.
Carsetti, R., Köhler, G., & Lamers, M. C. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.6.2129 · Cited by 357
Cutting Edge: The Chemokine Receptor CCR8 Is Preferentially Expressed in Th2 But Not Th1 Cells
Zingoni, A., Soto, H., Hedrick, J. A., Stoppacciaro, A., Storlazzi, C. T., Sinigaglia, F., D’Ambrosio, D., O’Garra, A., Robinson, D., Rocchi, M., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.547 · Cited by 357
IL-7 Licenses Activation of Human Liver Intrasinusoidal Mucosal-Associated Invariant T Cells
Tang, X.-Z., Jo, J., Tan, A. T., Sandalova, E., Chia, A., Tan, K. C., Lee, K. H., Gehring, A. J., De Libero, G., & Bertoletti, A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203218 · Cited by 356
Use of overlapping peptide mixtures as antigens for cytokine flow cytometry
Maecker, H. T., Dunn, H. S., Suni, M. A., Khatamzas, E., Pitcher, C. J., Bunde, T., Persaud, N., Trigona, W., Fu, T.-M., Sinclair, E., et al. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(01)00416-1 · Cited by 356
Roncarolo, M. G., Gregori, S., Bacchetta, R., Battaglia, M., & Gagliani, N. (2018) · Immunity · doi:10.1016/j.immuni.2018.12.001 · Cited by 355
Self-citationMenon, M., Blair, P. A., Isenberg, D. A., & Mauri, C. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.012 · Cited by 353
Induction of myelinating oligodendrocytes in human cortical spheroids
Madhavan, M., Nevin, Z. S., Shick, H. E., Garrison, E., Clarkson-Paredes, C., Karl, M., Clayton, B. L. L., Factor, D. C., Allan, K. C., Barbar, L., et al. (2018) · Nature Methods · doi:10.1038/s41592-018-0081-4 · Cited by 353
Professional Memory CD4+ T Lymphocytes Preferentially Reside and Rest in the Bone Marrow
Tokoyoda, K., Zehentmeier, S., Hegazy, A. N., Albrecht, I., Grün, J. R., Löhning, M., & Radbruch, A. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.015 · Cited by 352
Self-citationCamisaschi, C., Casati, C., Rini, F., Perego, M., De Filippo, A., Triebel, F., Parmiani, G., Belli, F., Rivoltini, L., & Castelli, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903879 · Cited by 350
Park, L. M., Lannigan, J., & Jaimes, M. C. (2020) · Cytometry Part A · doi:10.1002/cyto.a.24213 · Cited by 350
What is a natural killer cell?
Moretta, A., Bottino, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2002) · Nature Immunology · doi:10.1038/ni0102-6 · Cited by 349
Self-citationGoodman, T., & Lefrancois, L. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.5.1569 · Cited by 348
Design and use of conditional MHC class I ligands
Toebes, M., Coccoris, M., Bins, A., Rodenko, B., Gomez, R., Nieuwkoop, N. J., van de Kasteele, W., Rimmelzwaan, G. F., Haanen, J. B. A. G., Ovaa, H., et al. (2006) · Nature Medicine · doi:10.1038/nm1360 · Cited by 347
Lakshmikanth, T., Burke, S., Ali, T. H., Kimpfler, S., Ursini, F., Ruggeri, L., Capanni, M., Umansky, V., Paschen, A., Sucker, A., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36022 · Cited by 347
IL-2high tissue-resident T cells in the human liver: Sentinels for hepatotropic infection
Pallett, L. J., Davies, J., Colbeck, E. J., Robertson, F., Hansi, N., Easom, N. J. W., Burton, A. R., Stegmann, K. A., Schurich, A., Swadling, L., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162115 · Cited by 347
A Single Naive CD8+ T Cell Precursor Can Develop into Diverse Effector and Memory Subsets
Stemberger, C., Huster, K. M., Koffler, M., Anderl, F., Schiemann, M., Wagner, H., & Busch, D. H. (2007) · Immunity · doi:10.1016/j.immuni.2007.10.012 · Cited by 345
Self-citationDe Maria, A., Bozzano, F., Cantoni, C., & Moretta, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012356108 · Cited by 344
Self-citationThe phenotype and fate of the antibody‐forming cells of the splenic foci
Smith, K. G. C., Hewitson, T. D., Nossal, G. J. V., & Tarlinton, D. M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260226 · Cited by 344
Honjo, T. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.002435 · Cited by 344
Reiss, S., Baxter, A. E., Cirelli, K. M., Dan, J. M., Morou, A., Daigneault, A., Brassard, N., Silvestri, G., Routy, J.-P., Havenar-Daughton, C., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186998 · Cited by 343
Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity
Carmona-Rivera, C., & Kaplan, M. J. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0375-7 · Cited by 342
Marini, O., Costa, S., Bevilacqua, D., Calzetti, F., Tamassia, N., Spina, C., De Sabata, D., Tinazzi, E., Lunardi, C., Scupoli, M. T., et al. (2017) · Blood · doi:10.1182/blood-2016-04-713206 · Cited by 341
NK Cell Maturation and Peripheral Homeostasis Is Associated with KLRG1 Up-Regulation
Huntington, N. D., Tabarias, H., Fairfax, K., Brady, J., Hayakawa, Y., Degli-Esposti, M. A., Smyth, M. J., Tarlinton, D. M., & Nutt, S. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.4764 · Cited by 340
Maturation and persistence of the anti-SARS-CoV-2 memory B cell response
Sokal, A., Chappert, P., Barba-Spaeth, G., Roeser, A., Fourati, S., Azzaoui, I., Vandenberghe, A., Fernandez, I., Meola, A., Bouvier-Alias, M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.050 · Cited by 340
Self-citationIL-10–Producing Regulatory B Cells in the Pathogenesis of Chronic Hepatitis B Virus Infection
Das, A., Ellis, G., Pallant, C., Lopes, A. R., Khanna, P., Peppa, D., Chen, A., Blair, P., Dusheiko, G., Gill, U., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103139 · Cited by 339
Self-citationAjami, B., Samusik, N., Wieghofer, P., Ho, P. P., Crotti, A., Bjornson, Z., Prinz, M., Fantl, W. J., Nolan, G. P., & Steinman, L. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0100-x · Cited by 338
Modulation of CD1d-restricted NKT cell responses by using N- acyl variants of α-galactosylceramides
Yu, K. O. A., Im, J. S., Molano, A., Dutronc, Y., Illarionov, P. A., Forestier, C., Fujiwara, N., Arias, I., Miyake, S., Yamamura, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407488102 · Cited by 337
Self-citationBentzen, A. K., Marquard, A. M., Lyngaa, R., Saini, S. K., Ramskov, S., Donia, M., Such, L., Furness, A. J. S., McGranahan, N., Rosenthal, R., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3662 · Cited by 337
Bettelli, E., Baeten, D., Jäger, A., Sobel, R. A., & Kuchroo, V. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28334 · Cited by 336
Heterogeneity of Human CD4 + T Cells Against Microbes
Sallusto, F. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112056 · Cited by 336
Teunissen, M. B. M., Munneke, J. M., Bernink, J. H., Spuls, P. I., Res, P. C. M., te Velde, A., Cheuk, S., Brouwer, M. W. D., Menting, S. P., Eidsmo, L., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.146 · Cited by 335
Zhu, J., Jankovic, D., Oler, A. J., Wei, G., Sharma, S., Hu, G., Guo, L., Yagi, R., Yamane, H., Punkosdy, G., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.007 · Cited by 335
Meningeal γδ T cell-derived IL-17 controls synaptic plasticity and short-term memory
Ribeiro, M., Brigas, H. C., Temido-Ferreira, M., Pousinha, P. A., Regen, T., Santa, C., Coelho, J. E., Marques-Morgado, I., Valente, C. A., Omenetti, S., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aay5199 · Cited by 335
Brummelman, J., Mazza, E. M. C., Alvisi, G., Colombo, F. S., Grilli, A., Mikulak, J., Mavilio, D., Alloisio, M., Ferrari, F., Lopci, E., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180684 · Cited by 334
Amplification of B cell antigen receptor signaling by a Syk/ITAM positive feedback loop
Rolli, V., Gallwitz, M., Wossning, T., Flemming, A., Schamel, W. W. A., Zürn, C., & Reth, M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00739-6 · Cited by 331
Molecular and cellular origins of B lymphocyte diversity
Rolink, A., & Melchers, F. (1991) · Cell · doi:10.1016/0092-8674(91)90032-t · Cited by 330
Self-citationHighly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
Le Bert, N., Clapham, H. E., Tan, A. T., Chia, W. N., Tham, C. Y. L., Lim, J. M., Kunasegaran, K., Tan, L. W. L., Dutertre, C.-A., Shankar, N., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20202617 · Cited by 330
Self-citationTargeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus
Ostendorf, L., Burns, M., Durek, P., Heinz, G. A., Heinrich, F., Garantziotis, P., Enghard, P., Richter, U., Biesen, R., Schneider, U., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2023325 · Cited by 329
Self-citationB regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis
Schioppa, T., Moore, R., Thompson, R. G., Rosser, E. C., Kulbe, H., Nedospasov, S., Mauri, C., Coussens, L. M., & Balkwill, F. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100994108 · Cited by 328
Balazs, A. B., Fabian, A. J., Esmon, C. T., & Mulligan, R. C. (2006) · Blood · doi:10.1182/blood-2005-06-2249 · Cited by 328
Homeostasis of Peripheral B Cells in the Absence of B Cell Influx from the Bone Marrow
Hao, Z., & Rajewsky, K. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.8.1151 · Cited by 328
Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells
Gray, M., Miles, K., Salter, D., Gray, D., & Savill, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700326104 · Cited by 327
Nishimura, M., Umehara, H., Nakayama, T., Yoneda, O., Hieshima, K., Kakizaki, M., Dohmae, N., Yoshie, O., & Imai, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6173 · Cited by 326
Heterogeneity in the Differentiation and Function of CD8+ T Cells
Mittrücker, H.-W., Visekruna, A., & Huber, M. (2014) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-014-0293-y · Cited by 325
The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP.
Kozmik, Z., Wang, S., Dörfler, P., Adams, B., & Busslinger, M. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.6.2662 · Cited by 325
Reprogramming of CTLs into natural killer–like cells in celiac disease
Meresse, B., Curran, S. A., Ciszewski, C., Orbelyan, G., Setty, M., Bhagat, G., Lee, L., Tretiakova, M., Semrad, C., Kistner, E., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060028 · Cited by 322
Maintenance of B-cell memory by long-lived cells generated from proliferating precursors
Schittek, B., & Rajewsky, K. (1990) · Nature · doi:10.1038/346749a0 · Cited by 321
Savage, P. A., Klawon, D. E. J., & Miller, C. H. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-100219-020937 · Cited by 321
A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles
Chattopadhyay, P. K., Yu, J., & Roederer, M. (2005) · Nature Medicine · doi:10.1038/nm1293 · Cited by 320
Generation of peptide–MHC class I complexes through UV-mediated ligand exchange
Rodenko, B., Toebes, M., Hadrup, S. R., van Esch, W. J. E., Molenaar, A. M., Schumacher, T. N. M., & Ovaa, H. (2006) · Nature Protocols · doi:10.1038/nprot.2006.121 · Cited by 319
Regulatory T Cell Specificity Directs Tolerance versus Allergy against Aeroantigens in Humans
Bacher, P., Heinrich, F., Stervbo, U., Nienen, M., Vahldieck, M., Iwert, C., Vogt, K., Kollet, J., Babel, N., Sawitzki, B., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.050 · Cited by 319
Self-citationCD1d-lipid antigen recognition by the γδ TCR
Uldrich, A. P., Le Nours, J., Pellicci, D. G., Gherardin, N. A., McPherson, K. G., Lim, R. T., Patel, O., Beddoe, T., Gras, S., Rossjohn, J., et al. (2013) · Nature Immunology · doi:10.1038/ni.2713 · Cited by 318
Self-citationCai, X., Evrony, G. D., Lehmann, H. S., Elhosary, P. C., Mehta, B. K., Poduri, A., & Walsh, C. A. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.043 · Cited by 318
Eckle, S. B. G., Birkinshaw, R. W., Kostenko, L., Corbett, A. J., McWilliam, H. E. G., Reantragoon, R., Chen, Z., Gherardin, N. A., Beddoe, T., Liu, L., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140484 · Cited by 318
Self-citationSato, S., Fujimoto, M., Hasegawa, M., & Takehara, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20274 · Cited by 317
Mildner, A., Schönheit, J., Giladi, A., David, E., Lara-Astiaso, D., Lorenzo-Vivas, E., Paul, F., Chappell-Maor, L., Priller, J., Leutz, A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.018 · Cited by 317
Spangrude, G., Brooks, D., & Tumas, D. (1995) · Blood · doi:10.1182/blood.v85.4.1006.bloodjournal8541006 · Cited by 316
IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction
Jabri, B., & Abadie, V. (2015) · Nature Reviews Immunology · doi:10.1038/nri3919 · Cited by 315
Bakkus, M., Heirman, C., Van Riet, I., Van Camp, B., & Thielemans, K. (1992) · Blood · doi:10.1182/blood.v80.9.2326.2326 · Cited by 314
Functional heterogeneity of human memory CD4 + T cell clones primed by pathogens or vaccines
Becattini, S., Latorre, D., Mele, F., Foglierini, M., De Gregorio, C., Cassotta, A., Fernandez, B., Kelderman, S., Schumacher, T. N., Corti, D., et al. (2015) · Science · doi:10.1126/science.1260668 · Cited by 314
Self-citationUnconventional T Cell Targets for Cancer Immunotherapy
Godfrey, D. I., Le Nours, J., Andrews, D. M., Uldrich, A. P., & Rossjohn, J. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.009 · Cited by 314
Self-citationBacher, P., Rosati, E., Esser, D., Martini, G. R., Saggau, C., Schiminsky, E., Dargvainiene, J., Schröder, I., Wieters, I., Khodamoradi, Y., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.11.016 · Cited by 314
Intraepithelial T Cells of the TcRγ/δ+CD8− and Vδ1/Jδ1+ Phenotypes are Increased in Coeliac Disease
HALSTENSEN, T. S., SCOTT, H., & BRANDTZAEG, P. (1989) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1989.tb02474.x · Cited by 311
1,25‐dihydroxyvitamin D 3 promotes IL‐10 production in human B cells
Heine, G., Niesner, U., Chang, H., Steinmeyer, A., Zügel, U., Zuberbier, T., Radbruch, A., & Worm, M. (2008) · European Journal of Immunology · doi:10.1002/eji.200838216 · Cited by 311
Self-citationRole of ErbB Receptors in Cancer Cell Migration and Invasion
Appert-Collin, A., Hubert, P., Crémel, G., & Bennasroune, A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00283 · Cited by 310
The Role of Naive T Cell Precursor Frequency and Recruitment in Dictating Immune Response Magnitude
Jenkins, M. K., & Moon, J. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102661 · Cited by 309
Peripheral Blood CCR4+CCR6+ and CXCR3+CCR6+ CD4+ T Cells Are Highly Permissive to HIV-1 Infection
Gosselin, A., Monteiro, P., Chomont, N., Diaz-Griffero, F., Said, E. A., Fonseca, S., Wacleche, V., El-Far, M., Boulassel, M.-R., Routy, J.-P., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903058 · Cited by 309
A new CD21low B cell population in the peripheral blood of patients with SLE
Wehr, C., Eibel, H., Masilamani, M., Illges, H., Schlesier, M., Peter, H.-H., & Warnatz, K. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.05.010 · Cited by 308
Self-citationNeves, P., Lampropoulou, V., Calderon-Gomez, E., Roch, T., Stervbo, U., Shen, P., Kühl, A. A., Loddenkemper, C., Haury, M., Nedospasov, S. A., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.016 · Cited by 308
Self-citationWatanabe, R., Ishiura, N., Nakashima, H., Kuwano, Y., Okochi, H., Tamaki, K., Sato, S., Tedder, T. F., & Fujimoto, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902385 · Cited by 308
Van Camp, B., Durie, B., Spier, C., De Waele, M., Van Riet, I., Vela, E., Frutiger, Y., Richter, L., & Grogan, T. (1990) · Blood · doi:10.1182/blood.v76.2.377.377 · Cited by 307
Life after the thymus: CD31+ and CD31− human naive CD4+ T-cell subsets
Kohler, S., & Thiel, A. (2009) · Blood · doi:10.1182/blood-2008-02-139154 · Cited by 307
Memory B Cells of Mice and Humans
Weisel, F., & Shlomchik, M. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055531 · Cited by 307
Gerosa, F., Paganin, C., Peritt, D., Paiola, F., Scupoli, M. T., Aste-Amezaga, M., Frank, I., & Trinchieri, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2559 · Cited by 306
Hadrup, S. R., Bakker, A. H., Shu, C. J., Andersen, R. S., van Veluw, J., Hombrink, P., Castermans, E., thor Straten, P., Blank, C., Haanen, J. B., et al. (2009) · Nature Methods · doi:10.1038/nmeth.1345 · Cited by 306
Thome, J. J. C., Bickham, K. L., Ohmura, Y., Kubota, M., Matsuoka, N., Gordon, C., Granot, T., Griesemer, A., Lerner, H., Kato, T., et al. (2016) · Nature Medicine · doi:10.1038/nm.4008 · Cited by 305
Manz, R., Assenmacher, M., Pflüger, E., Miltenyi, S., & Radbruch, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.1921 · Cited by 303
Self-citationNewell, E. W., Sigal, N., Nair, N., Kidd, B. A., Greenberg, H. B., & Davis, M. M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2593 · Cited by 302
Cosmi, L., Maggi, L., Santarlasci, V., Capone, M., Cardilicchia, E., Frosali, F., Querci, V., Angeli, R., Matucci, A., Fambrini, M., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.012 · Cited by 302
Self-citationOhteki, T., & MacDonald, H. R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.699 · Cited by 300
IL-10-producing regulatory B cells (B10 cells) in autoimmune disease
Kalampokis, I., Yoshizaki, A., & Tedder, T. F. (2013) · Arthritis Research & Therapy · doi:10.1186/ar3907 · Cited by 300
Kwakkenbos, M. J., Diehl, S. A., Yasuda, E., Bakker, A. Q., van Geelen, C. M. M., Lukens, M. V., van Bleek, G. M., Widjojoatmodjo, M. N., Bogers, W. M. J. M., Mei, H., et al. (2010) · Nature Medicine · doi:10.1038/nm.2071 · Cited by 300
Self-citationMucosal-associated invariant T cells and disease
Toubal, A., Nel, I., Lotersztajn, S., & Lehuen, A. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0191-y · Cited by 300
Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response
Lee, Y. J., Wang, H., Starrett, G. J., Phuong, V., Jameson, S. C., & Hogquist, K. A. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.025 · Cited by 299
Agematsu, K., Nagumo, H., Yang, F., Nakazawa, T., Fukushima, K., Ito, S., Sugita, K., Mori, T., Kobata, T., Morimoto, C., et al. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270835 · Cited by 299
New criteria for response assessment: role of minimal residual disease in multiple myeloma
Paiva, B., van Dongen, J. J. M., & Orfao, A. (2015) · Blood · doi:10.1182/blood-2014-11-568907 · Cited by 299
Biology of CD1- and MR1-Restricted T Cells
Salio, M., Silk, J. D., Yvonne Jones, E., & Cerundolo, V. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120243 · Cited by 299
Two subsets of stem-like CD8+ memory T cell progenitors with distinct fate commitments in humans
Galletti, G., De Simone, G., Mazza, E. M. C., Puccio, S., Mezzanotte, C., Bi, T. M., Davydov, A. N., Metsger, M., Scamardella, E., Alvisi, G., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0791-5 · Cited by 299
Self-citationIsolation of mouse mesenchymal stem cells on the basis of expression of Sca-1 and PDGFR-α
Houlihan, D. D., Mabuchi, Y., Morikawa, S., Niibe, K., Araki, D., Suzuki, S., Okano, H., & Matsuzaki, Y. (2012) · Nature Protocols · doi:10.1038/nprot.2012.125 · Cited by 297
Kräutler, N. J., Suan, D., Butt, D., Bourne, K., Hermes, J. R., Chan, T. D., Sundling, C., Kaplan, W., Schofield, P., Jackson, J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161533 · Cited by 297
Buggert, M., Tauriainen, J., Yamamoto, T., Frederiksen, J., Ivarsson, M. A., Michaëlsson, J., Lund, O., Hejdeman, B., Jansson, M., Sönnerborg, A., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004251 · Cited by 296
Davey, M. S., Willcox, C. R., Joyce, S. P., Ladell, K., Kasatskaya, S. A., McLaren, J. E., Hunter, S., Salim, M., Mohammed, F., Price, D. A., et al. (2017) · Nature Communications · doi:10.1038/ncomms14760 · Cited by 296
Self-citationRankin, L. C., Groom, J. R., Chopin, M., Herold, M. J., Walker, J. A., Mielke, L. A., McKenzie, A. N. J., Carotta, S., Nutt, S. L., & Belz, G. T. (2013) · Nature Immunology · doi:10.1038/ni.2545 · Cited by 294
Day, C. L., Seth, N. P., Lucas, M., Appel, H., Gauthier, L., Lauer, G. M., Robbins, G. K., Szczepiorkowski, Z. M., Casson, D. R., Chung, R. T., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18509 · Cited by 294
Blair, P. A., Chavez-Rueda, K. A., Evans, J. G., Shlomchik, M. J., Eddaoudi, A., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803052 · Cited by 291
Memory B and memory plasma cells
Yoshida, T., Mei, H., Dörner, T., Hiepe, F., Radbruch, A., Fillatreau, S., & Hoyer, B. F. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00938.x · Cited by 289
Self-citationThe macrophage capacity for phagocytosis
Cannon, G. J., & Swanson, J. A. (1992) · Journal of Cell Science · doi:10.1242/jcs.101.4.907 · Cited by 289
Jacobi, A. M., Reiter, K., Mackay, M., Aranow, C., Hiepe, F., Radbruch, A., Hansen, A., Burmester, G., Diamond, B., Lipsky, P. E., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23498 · Cited by 289
Self-citationReddy, M., Eirikis, E., Davis, C., Davis, H. M., & Prabhakar, U. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.07.006 · Cited by 288
Pathogenesis beyond the cancer clone(s) in multiple myeloma
Bianchi, G., & Munshi, N. C. (2015) · Blood · doi:10.1182/blood-2014-11-568881 · Cited by 288
Frey, M., Packianathan, N. B., Fehniger, T. A., Ross, M. E., Wang, W.-C., Stewart, C. C., Caligiuri, M. A., & Evans, S. S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.400 · Cited by 287
Medina, F., Segundo, C., Campos-Caro, A., González-Garcı́a, I., & Brieva, J. A. (2002) · Blood · doi:10.1182/blood.v99.6.2154 · Cited by 286
Markers for Characterization of Bone Marrow Multipotential Stromal Cells
Boxall, S. A., & Jones, E. (2012) · Stem Cells International · doi:10.1155/2012/975871 · Cited by 286
CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells
Juelke, K., Killig, M., Luetke-Eversloh, M., Parente, E., Gruen, J., Morandi, B., Ferlazzo, G., Thiel, A., Schmitt-Knosalla, I., & Romagnani, C. (2010) · Blood · doi:10.1182/blood-2009-11-253286 · Cited by 286
Self-citationGeneration and persistence of human tissue-resident memory T cells in lung transplantation
Snyder, M. E., Finlayson, M. O., Connors, T. J., Dogra, P., Senda, T., Bush, E., Carpenter, D., Marboe, C., Benvenuto, L., Shah, L., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aav5581 · Cited by 286
Developmental plasticity allows outside-in immune responses by resident memory T cells
Fonseca, R., Beura, L. K., Quarnstrom, C. F., Ghoneim, H. E., Fan, Y., Zebley, C. C., Scott, M. C., Fares-Frederickson, N. J., Wijeyesinghe, S., Thompson, E. A., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0607-7 · Cited by 286
Carter, N. A., Rosser, E. C., & Mauri, C. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3736 · Cited by 284
A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging
Lanna, A., Gomes, D. C. O., Muller-Durovic, B., McDonnell, T., Escors, D., Gilroy, D. W., Lee, J. H., Karin, M., & Akbar, A. N. (2017) · Nature Immunology · doi:10.1038/ni.3665 · Cited by 284
Toker, A., Engelbert, D., Garg, G., Polansky, J. K., Floess, S., Miyao, T., Baron, U., Düber, S., Geffers, R., Giehr, P., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203473 · Cited by 283
Self-citationIntraepithelial lymphocytes of the small intestine.
Ferguson, A. (1977) · Gut · doi:10.1136/gut.18.11.921 · Cited by 283
B10 Cells: A Functionally Defined Regulatory B Cell Subset
Tedder, T. F. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401329 · Cited by 283
Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma
Paiva, B., Puig, N., Cedena, M.-T., Rosiñol, L., Cordón, L., Vidriales, M.-B., Burgos, L., Flores-Montero, J., Sanoja-Flores, L., Lopez-Anglada, L., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.01231 · Cited by 283
Brown, D. M., Dilzer, A. M., Meents, D. L., & Swain, S. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.2888 · Cited by 282
Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissues
Delacher, M., Imbusch, C. D., Weichenhan, D., Breiling, A., Hotz-Wagenblatt, A., Träger, U., Hofer, A.-C., Kägebein, D., Wang, Q., Frauhammer, F., et al. (2017) · Nature Immunology · doi:10.1038/ni.3799 · Cited by 282
Self-citationThe transcriptional program of terminal granulocytic differentiation
Theilgaard-Mönch, K., Jacobsen, L. C., Borup, R., Rasmussen, T., Bjerregaard, M. D., Nielsen, F. C., Cowland, J. B., & Borregaard, N. (2005) · Blood · doi:10.1182/blood-2004-08-3346 · Cited by 281
Brigl, M., Tatituri, R. V. V., Watts, G. F. M., Bhowruth, V., Leadbetter, E. A., Barton, N., Cohen, N. R., Hsu, F.-F., Besra, G. S., & Brenner, M. B. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102555 · Cited by 281
Characterization of the early stages of thymic NKT cell development
Benlagha, K., Wei, D. G., Veiga, J., Teyton, L., & Bendelac, A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050456 · Cited by 281
LAG-3 Inhibitory Receptor Expression Identifies Immunosuppressive Natural Regulatory Plasma Cells
Lino, A. C., Dang, V. D., Lampropoulou, V., Welle, A., Joedicke, J., Pohar, J., Simon, Q., Thalmensi, J., Baures, A., Flühler, V., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.06.007 · Cited by 277
Self-citationDuda, D. G., Cohen, K. S., Scadden, D. T., & Jain, R. K. (2007) · Nature Protocols · doi:10.1038/nprot.2007.111 · Cited by 275
Role of antigen receptor affinity in T cell–independent antibody responses in vivo
Shih, T.-A. Y., Roederer, M., & Nussenzweig, M. C. (2002) · Nature Immunology · doi:10.1038/ni776 · Cited by 274
Rincon-Arevalo, H., Choi, M., Stefanski, A.-L., Halleck, F., Weber, U., Szelinski, F., Jahrsdörfer, B., Schrezenmeier, H., Ludwig, C., Sattler, A., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abj1031 · Cited by 273
Self-citationAdvances in Human B Cell Phenotypic Profiling
Kaminski, D. A., Wei, C., Qian, Y., Rosenberg, A. F., & Sanz, I. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00302 · Cited by 272
Ravens, S., Schultze-Florey, C., Raha, S., Sandrock, I., Drenker, M., Oberdörfer, L., Reinhardt, A., Ravens, I., Beck, M., Geffers, R., et al. (2017) · Nature Immunology · doi:10.1038/ni.3686 · Cited by 271
Self-citationT-bet is required for optimal proinflammatory CD4+ T-cell trafficking
Lord, G. M. (2005) · Blood · doi:10.1182/blood-2005-04-1393 · Cited by 270
Langerhans cells - the macrophage in dendritic cell clothing
Doebel, T., Voisin, B., & Nagao, K. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.06.008 · Cited by 270
The Protean Nature of Cells in the B Lymphocyte Lineage
Hardy, R. R., Kincade, P. W., & Dorshkind, K. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.013 · Cited by 269
Blood-borne human plasma cells in steady state are derived from mucosal immune responses
Mei, H. E., Yoshida, T., Sime, W., Hiepe, F., Thiele, K., Manz, R. A., Radbruch, A., & Dörner, T. (2009) · Blood · doi:10.1182/blood-2008-04-153544 · Cited by 269
Self-citationDaniels, M. A., & Jameson, S. C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.335 · Cited by 269
Plasma cell development and survival
Oracki, S. A., Walker, J. A., Hibbs, M. L., Corcoran, L. M., & Tarlinton, D. M. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00940.x · Cited by 268
Hacbarth, E., & Kajdacsy‐Balla, A. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291105 · Cited by 268
Intracellular cytokine optimization and standard operating procedure
Lamoreaux, L., Roederer, M., & Koup, R. (2006) · Nature Protocols · doi:10.1038/nprot.2006.268 · Cited by 268
Exacerbation of ulcerative colitis after rituximab salvage therapy
Goetz, M., Atreya, R., Ghalibafian, M., Galle, P. R., & Neurath, M. F. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20215 · Cited by 268
Human blood MAIT cell subsets defined using MR1 tetramers
Gherardin, N. A., Souter, M. N., Koay, H., Mangas, K. M., Seemann, T., Stinear, T. P., Eckle, S. B., Berzins, S. P., d'Udekem, Y., Konstantinov, I. E., et al. (2018) · Immunology & Cell Biology · doi:10.1111/imcb.12021 · Cited by 267
Self-citationYilmaz, O. H., Kiel, M. J., & Morrison, S. J. (2006) · Blood · doi:10.1182/blood-2005-05-2140 · Cited by 266
Initiation of Plasma-Cell Differentiation Is Independent of the Transcription Factor Blimp-1
Kallies, A., Hasbold, J., Fairfax, K., Pridans, C., Emslie, D., McKenzie, B. S., Lew, A. M., Corcoran, L. M., Hodgkin, P. D., Tarlinton, D. M., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.04.007 · Cited by 266
Loh, L., Wang, Z., Sant, S., Koutsakos, M., Jegaskanda, S., Corbett, A. J., Liu, L., Fairlie, D. P., Crowe, J., Rossjohn, J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610750113 · Cited by 265
Self-citationBedner, E., Smolewski, P., Amstad, P., & Darzynkiewicz, Z. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4955 · Cited by 264
Dan, J. M., Lindestam Arlehamn, C. S., Weiskopf, D., da Silva Antunes, R., Havenar-Daughton, C., Reiss, S. M., Brigger, M., Bothwell, M., Sette, A., & Crotty, S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600318 · Cited by 264
Kwok, I., Becht, E., Xia, Y., Ng, M., Teh, Y. C., Tan, L., Evrard, M., Li, J. L. Y., Tran, H. T. N., Tan, Y., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.005 · Cited by 264
Self-citationMcMichael, A. J., & O'Callaghan, C. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1367 · Cited by 263
Lopez, J. A., Susanto, O., Jenkins, M. R., Lukoyanova, N., Sutton, V. R., Law, R. H. P., Johnston, A., Bird, C. H., Bird, P. I., Whisstock, J. C., et al. (2013) · Blood · doi:10.1182/blood-2012-07-446146 · Cited by 262
The CD19/CD21 signal transduction complex of B lymphocytes
Tedder, T. F., Zhou, L.-J., & Engel, P. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90274-7 · Cited by 262
Immune Evasion Strategies of Glioblastoma
Razavi, S.-M., Lee, K. E., Jin, B. E., Aujla, P. S., Gholamin, S., & Li, G. (2016) · Frontiers in Surgery · doi:10.3389/fsurg.2016.00011 · Cited by 262
Quinn, K. M., Fox, A., Harland, K. L., Russ, B. E., Li, J., Nguyen, T. H. O., Loh, L., Olshanksy, M., Naeem, H., Tsyganov, K., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.057 · Cited by 262
Flores‐Montero, J., de Tute, R., Paiva, B., Perez, J. J., Böttcher, S., Wind, H., Sanoja, L., Puig, N., Lecrevisse, Q., Vidriales, M. B., et al. (2016) · Cytometry Part B: Clinical Cytometry · doi:10.1002/cyto.b.21265 · Cited by 261
Jabri, B., De Serre, N. P., Cellier, C., Evans, K., Gache, C., Carvalho, C., Mougenot, J., Allez, M., Jian, R., Desreumaux, P., et al. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70173-9 · Cited by 261
BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms
Hatzi, K., Nance, J. P., Kroenke, M. A., Bothwell, M., Haddad, E. K., Melnick, A., & Crotty, S. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141380 · Cited by 261
New markers for murine memory B cells that define mutated and unmutated subsets
Anderson, S. M., Tomayko, M. M., Ahuja, A., Haberman, A. M., & Shlomchik, M. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062571 · Cited by 261
Markers of T Cell Senescence in Humans
Xu, W., & Larbi, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081742 · Cited by 261
Ecker, J. R., Geschwind, D. H., Kriegstein, A. R., Ngai, J., Osten, P., Polioudakis, D., Regev, A., Sestan, N., Wickersham, I. R., & Zeng, H. (2017) · Neuron · doi:10.1016/j.neuron.2017.10.007 · Cited by 261
Delacher, M., Imbusch, C. D., Hotz-Wagenblatt, A., Mallm, J.-P., Bauer, K., Simon, M., Riegel, D., Rendeiro, A. F., Bittner, S., Sanderink, L., et al. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.002 · Cited by 261
Self-citationKarunakaran, M. M., Willcox, C. R., Salim, M., Paletta, D., Fichtner, A. S., Noll, A., Starick, L., Nöhren, A., Begley, C. R., Berwick, K. A., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.02.014 · Cited by 261
Cross-reactive memory T cells and herd immunity to SARS-CoV-2
Lipsitch, M., Grad, Y. H., Sette, A., & Crotty, S. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00460-4 · Cited by 260
Somatic Hypermutation of Immunoglobulin Genes
Papavasiliou, F. N., & Schatz, D. G. (2002) · Cell · doi:10.1016/s0092-8674(02)00706-7 · Cited by 259
Terstappen, L., Johnsen, S., Segers-Nolten, I., & Loken, M. (1990) · Blood · doi:10.1182/blood.v76.9.1739.1739 · Cited by 259
Role of regulatory B cells in immune tolerance to allergens and beyond
van de Veen, W., Stanic, B., Wirz, O. F., Jansen, K., Globinska, A., & Akdis, M. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.07.006 · Cited by 258
Self-citationRapid and Massive Virus-Specific Plasmablast Responses during Acute Dengue Virus Infection in Humans
Wrammert, J., Onlamoon, N., Akondy, R. S., Perng, G. C., Polsrila, K., Chandele, A., Kwissa, M., Pulendran, B., Wilson, P. C., Wittawatmongkol, O., et al. (2012) · Journal of Virology · doi:10.1128/jvi.06075-11 · Cited by 257
Litzenburger, T., Fässler, R., Bauer, J., Lassmann, H., Linington, C., Wekerle, H., & Iglesias, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.169 · Cited by 256
Living and dying for inflammation: neutrophils, eosinophils, basophils
Geering, B., Stoeckle, C., Conus, S., & Simon, H.-U. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.04.002 · Cited by 256
Day, C. L., Seth, N. P., Lucas, M., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318509 · Cited by 256
Considerations for the control of background fluorescence in clinical flow cytometry
Hulspas, R., O'Gorman, M. R. G., Wood, B. L., Gratama, J. W., & Sutherland, D. R. (2009) · Cytometry Part B: Clinical Cytometry · doi:10.1002/cyto.b.20485 · Cited by 255
Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells
Walker, L. J., Kang, Y.-H., Smith, M. O., Tharmalingham, H., Ramamurthy, N., Fleming, V. M., Sahgal, N., Leslie, A., Oo, Y., Geremia, A., et al. (2012) · Blood · doi:10.1182/blood-2011-05-353789 · Cited by 255
Caraux, A., Klein, B., Paiva, B., Bret, C., Schmitz, A., Fuhler, G. M., Bos, N. A., Johnsen, H. E., Orfao, A., Perez-Andres, M., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.018689 · Cited by 255
Della Chiesa, M., Falco, M., Podestà, M., Locatelli, F., Moretta, L., Frassoni, F., & Moretta, A. (2012) · Blood · doi:10.1182/blood-2011-08-372003 · Cited by 254
Self-citationCutting Edge: Identification and Characterization of Human Intrahepatic CD49a+ NK Cells
Marquardt, N., Béziat, V., Nyström, S., Hengst, J., Ivarsson, M. A., Kekäläinen, E., Johansson, H., Mjösberg, J., Westgren, M., Lankisch, T. O., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402756 · Cited by 254
Predominant expression of invariant Vα14+ TCR α chain in NK1.1+ T cell populations
Makino, Y., Kanno, R., Ito, T., Higashino, K., & Taniguchi, M. (1995) · International Immunology · doi:10.1093/intimm/7.7.1157 · Cited by 253
Crellin, N. K., Trifari, S., Kaplan, C. D., Satoh-Takayama, N., Di Santo, J. P., & Spits, H. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.012 · Cited by 252
Self-citationIntestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier
Olivares-Villagómez, D., & Van Kaer, L. (2018) · Trends in Immunology · doi:10.1016/j.it.2017.11.003 · Cited by 252
Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells
Wang, R., Kozhaya, L., Mercer, F., Khaitan, A., Fujii, H., & Unutmaz, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901965106 · Cited by 251
Biological Roles of Neutrophil-Derived Granule Proteins and Cytokines
Cassatella, M. A., Östberg, N. K., Tamassia, N., & Soehnlein, O. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.05.003 · Cited by 249
Lansdorp, P. M., Sutherland, H. J., & Eaves, C. J. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.1.363 · Cited by 248
Gallo, O., Locatello, L. G., Mazzoni, A., Novelli, L., & Annunziato, F. (2021) · Mucosal Immunology · doi:10.1038/s41385-020-00359-2 · Cited by 248
Self-citationParks, D. R., Roederer, M., & Moore, W. A. (2006) · Cytometry Part A · doi:10.1002/cyto.a.20258 · Cited by 246
Reese, T. A., Bi, K., Kambal, A., Filali-Mouhim, A., Beura, L. K., Bürger, M. C., Pulendran, B., Sekaly, R.-P., Jameson, S. C., Masopust, D., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.04.003 · Cited by 246
Antibody-secreting plasma cells persist for decades in human intestine
Landsverk, O. J. B., Snir, O., Casado, R. B., Richter, L., Mold, J. E., Réu, P., Horneland, R., Paulsen, V., Yaqub, S., Aandahl, E. M., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161590 · Cited by 245
Dress, R. J., Dutertre, C.-A., Giladi, A., Schlitzer, A., Low, I., Shadan, N. B., Tay, A., Lum, J., Kairi, M. F. B. M., Hwang, Y. Y., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0420-3 · Cited by 245
Self-citationCutting Edge: Hierarchy of Maturity of Murine Memory B Cell Subsets
Tomayko, M. M., Steinel, N. C., Anderson, S. M., & Shlomchik, M. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002163 · Cited by 244
Montoya, C. J., Pollard, D., Martinson, J., Kumari, K., Wasserfall, C., Mulder, C. B., Rugeles, M. T., Atkinson, M. A., Landay, A. L., & Wilson, S. B. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02647.x · Cited by 243
Kikuchi, K., Lai, A. Y., Hsu, C.-L., & Kondo, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050158 · Cited by 243
Standardization of cytokine flow cytometry assays
Maecker, H. T., Rinfret, A., D'Souza, P., Darden, J., Roig, E., Landry, C., Hayes, P., Birungi, J., Anzala, O., Garcia, M., et al. (2005) · BMC Immunology · doi:10.1186/1471-2172-6-13 · Cited by 241
Halary, F., Pitard, V., Dlubek, D., Krzysiek, R., de la Salle, H., Merville, P., Dromer, C., Emilie, D., Moreau, J.-F., & Déchanet-Merville, J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041851 · Cited by 241
Parekh, V. V., Prasad, D. V. R., Banerjee, P. P., Joshi, B. N., Kumar, A., & Mishra, G. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.5897 · Cited by 240
Bermejo, D. A., Jackson, S. W., Gorosito-Serran, M., Acosta-Rodriguez, E. V., Amezcua-Vesely, M. C., Sather, B. D., Singh, A. K., Khim, S., Mucci, J., Liggitt, D., et al. (2013) · Nature Immunology · doi:10.1038/ni.2569 · Cited by 237
Development of psoriasis after B cell depletion with rituximab
Dass, S., Vital, E. M., & Emery, P. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22811 · Cited by 237
Humanized Mouse Xenograft Models: Narrowing the Tumor–Microenvironment Gap
Morton, J. J., Bird, G., Refaeli, Y., & Jimeno, A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1260 · Cited by 237
Correia, D. V., Fogli, M., Hudspeth, K., da Silva, M. G., Mavilio, D., & Silva-Santos, B. (2011) · Blood · doi:10.1182/blood-2011-02-339135 · Cited by 236
Selective Mobilization of Cytotoxic Leukocytes by Epinephrine
Dimitrov, S., Lange, T., & Born, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902189 · Cited by 236
CXCR6 marks a novel subset of T-betloEomeshi natural killer cells residing in human liver
Stegmann, K. A., Robertson, F., Hansi, N., Gill, U., Pallant, C., Christophides, T., Pallett, L. J., Peppa, D., Dunn, C., Fusai, G., et al. (2016) · Scientific Reports · doi:10.1038/srep26157 · Cited by 235
The end of gating? An introduction to automated analysis of high dimensional cytometry data
Mair, F., Hartmann, F. J., Mrdjen, D., Tosevski, V., Krieg, C., & Becher, B. (2016) · European Journal of Immunology · doi:10.1002/eji.201545774 · Cited by 234
Self-citationNatural Killer T Cells in Cancer Immunotherapy
Nair, S., & Dhodapkar, M. V. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01178 · Cited by 234
CytoNorm: A Normalization Algorithm for Cytometry Data
Van Gassen, S., Gaudilliere, B., Angst, M. S., Saeys, Y., & Aghaeepour, N. (2020) · Cytometry Part A · doi:10.1002/cyto.a.23904 · Cited by 234
Elie Metchnikoff: Father of natural immunity
Gordon, S. (2008) · European Journal of Immunology · doi:10.1002/eji.200838855 · Cited by 232
Kikutani, H., Suemura, M., Owaki, H., Nakamura, H., Sato, R., Yamasaki, K., Barsumian, E. L., Hardy, R. R., & Kishimoto, T. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.5.1455 · Cited by 232
Phan, T. G., Amesbury, M., Gardam, S., Crosbie, J., Hasbold, J., Hodgkin, P. D., Basten, A., & Brink, R. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022144 · Cited by 231
TCR Transgenic Mice Reveal Stepwise, Multi-site Acquisition of the Distinctive Fat-Treg Phenotype
Li, C., DiSpirito, J. R., Zemmour, D., Spallanzani, R. G., Kuswanto, W., Benoist, C., & Mathis, D. (2018) · Cell · doi:10.1016/j.cell.2018.05.004 · Cited by 231
IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease
Abadie, V., Kim, S. M., Lejeune, T., Palanski, B. A., Ernest, J. D., Tastet, O., Voisine, J., Discepolo, V., Marietta, E. V., Hawash, M. B. F., et al. (2020) · Nature · doi:10.1038/s41586-020-2003-8 · Cited by 231
Crozat, K., Tamoutounour, S., Vu Manh, T.-P., Fossum, E., Luche, H., Ardouin, L., Guilliams, M., Azukizawa, H., Bogen, B., Malissen, B., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101717 · Cited by 230
Research works printed but not linked: 9
- Häringer B, Lozza L, Steckel B and Geginat J, Identification and characterization of IL-10/IFN-γ-producing effector-like T cells with regulatory function in human blood. J. Exp. Med 2009. 206: 1009– 1017. Available from: https://pubmed.ncbi.nlm.nih.gov/19414553/ 19414553 PMC2715038 · DOI · Paper page
- Liu Y, Goff RD, Zhou D, Mattner J, Sullivan BA, Khurana A, Cantu C 3rd, A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells. J. Immunol. Methods 2006. 312: 34– 39. 16647712 · DOI · Paper page
- Gherardin NA, Souter MNT, Koay HF, Mangas KM, Seemann T, Stinear TP, Eckle SBG, Human blood MAIT cell subsets defined using MR1 tetramers. Immunol. Cell Biol 2018. PMC6446826 29437263 · DOI · Paper page
- Grifoni A, Weiskopf D, Ramirez SI, Mateus J, Dan JM, Moderbacher CR, Rawlings SA, Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell 2020. 181: 1489– 501.e15. 32473127 PMC7237901 · DOI · Paper page
- Gangaev A, Ketelaars SLC, Patiwael S, Dopler A, Isaeva OI, Hoefakker K, De Biasi S, Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features. Nat. Commun 2021. 12: 2593. 33972535 PMC8110804 · DOI · Paper page
- Halliley JL, Tipton CM, Liesveld J, Rosenberg AF, Darce J, Gregoretti IV, Popova L, Long-lived plasma cells are contained within the CD19(−)CD38(hi)CD138(+) subset in human bone marrow. Immunity 2015. 43: 132– 145. 26187412 PMC4680845 · DOI · Paper page
- 10.1002/(SICI)1097-0320(19961215)26:4<243::AID-CYTO2>3.0.CO;2-D · DOI
- Metchnikoff E. Leçons Sur La Pathologie Comparée De L’inflammation. Paris: Masson. 1892.
- Vikhanski L. mmunity: How Elie Metchnikoff changed the course of modern medicine. Chicago Review Press. 2016.
Cited by
Clonal expansion and epigenetic inheritance of long-lasting NK cell memory
Rückert, T., Lareau, C. A., Mashreghi, M.-F., Ludwig, L. S., & Romagnani, C. (2022) · Nature Immunology · doi:10.1038/s41590-022-01327-7 · Cited by 190
Self-citationHigh-Dimensional Single-Cell Multimodal Landscape of Human Carotid Atherosclerosis
Bashore, A. C., Yan, H., Xue, C., Zhu, L. Y., Kim, E., Mawson, T. L., Coronel, J., Chung, A. Y., Sachs, N., Ho, S., et al. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.320524 · Cited by 140
Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection
Wiech, M., Chrościcki, P., Swatler, J., Stępnik, D., Biasi, S. D., Hampel, M., Brewińska‐Olchowik, M., Maliszewska, A., Sklinda, K., Durlik, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.886431 · Cited by 112
“Isolation of peripheral blood mononuclear cells (PBMC) was performed using ficoll-hypaque (Lymphoprep, Stem Cell) according to standard procedures (34).”
MethodSelf-citationExtricating human tumour immune alterations from tissue inflammation
Mair, F., Erickson, J. R., Frutoso, M., Konecny, A., Greene, E., Voillet, V., Maurice, N. J., Rongvaux, A., Dixon, D. R., Barber, B. R., et al. (2022) · Nature · doi:10.1038/s41586-022-04718-w · Cited by 115
Self-citationCroce, G., Bobisse, S., Moreno, D. L., Schmidt, J., Guillame, P., Harari, A., & Gfeller, D. (2024) · Nature Communications · doi:10.1038/s41467-024-47461-8 · Cited by 102
“These regions, referred to as complementarity-determining regions 3 (CDR3), are mainly involved in the recognition of the epitope, while two other CDRs (CDR1 and CDR2) located on the V segments mediate contact primarily with the MHC 12 .”
Metadata
- Authors
- Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., Bacher, P., Bari, S., Barnaba, V., Barros‐Martins, J., Baumjohann, D., Beccaria, C. G., Bernardo, D., Boardman, D. A., Borger, J., Böttcher, C., Brockmann, L., Burns, M., Busch, D. H., Cameron, G., Cammarata, I., Cassotta, A., Chang, Y., Chirdo, F. G., Christakou, E., Čičin‐Šain, L., Cook, L., Corbett, A. J., Cornelis, R., Cosmi, L., Davey, M. S., De Biasi, S., De Simone, G., del Zotto, G., Delacher, M., Di Rosa, F., Di Santo, J., Diefenbach, A., Dong, J., Dörner, T., Dress, R. J., Dutertre, C., Eckle, S. B. G., Eede, P., Evrard, M., Falk, C. S., Feuerer, M., Fillatreau, S., Fiz‐Lopez, A., Follo, M., Foulds, G. A., Fröbel, J., Gagliani, N., Galletti, G., Gangaev, A., Garbi, N., Garrote, J. A., Geginat, J., Gherardin, N. A., Gibellini, L., Ginhoux, F., Godfrey, D. I., Gruarin, P., Haftmann, C., Hansmann, L., Harpur, C. M., Hayday, A. C., Heine, G., Hernández, D. C., Herrmann, M., Hoelsken, O., Huang, Q., Huber, S., Huber, J. E., Huehn, J., Hundemer, M., Hwang, W. Y. K., Iannacone, M., Ivison, S. M., Jäck, H., Jani, P. K., Keller, B., Kessler, N., Ketelaars, S., Knop, L., Knopf, J., Koay, H., Kobow, K., Kriegsmann, K., Kristyanto, H., Krueger, A., Kuehne, J. F., Kunze‐Schumacher, H., Kvistborg, P., Kwok, I., Latorre, D., Lenz, D., Levings, M. K., Lino, A. C., Liotta, F., Long, H. M., Lugli, E., MacDonald, K. N., Maggi, L., Maini, M. K., Mair, F., Manta, C., Manz, R. A., Mashreghi, M., Mazzoni, A., McCluskey, J., Mei, H. E., Melchers, F., Melzer, S., Mielenz, D., Monin, L., Moretta, L., Multhoff, G., Muñoz, L. E., Muñoz‐Ruiz, M., Muscate, F., Natalini, A., Neumann, K., Ng, L. G., Niedobitek, A., Niemz, J., Almeida, L. N., Notarbartolo, S., Ostendorf, L., Pallett, L. J., Patel, A. A., Percin, G. I., Peruzzi, G., Pinti, M., Pockley, A. G., Pracht, K., Prinz, I., Pujol‐Autonell, I., Pulvirenti, N., Quatrini, L., Quinn, K. M., Radbruch, H., Rhys, H., Rodrigo, M. B., Romagnani, C., Saggau, C., Sakaguchi, S., Sallusto, F., Sanderink, L., Sandrock, I., Schauer, C., Scheffold, A., Scherer, H. U., Schiemann, M., Schildberg, F. A., Schober, K., Schoen, J., Schuh, W., Schüler, T., Schulz, A. R., Schulz, S., Schulze, J., Simonetti, S., Singh, J., Sitnik, K. M., Stark, R., Starossom, S., Stehle, C., Szelinski, F., Tan, L., Tarnok, A., Tornack, J., Tree, T. I. M., van Beek, J. J. P., van de Veen, W., van Gisbergen, K., Vasco, C., Verheyden, N. A., von Borstel, A., Ward‐Hartstonge, K. A., Warnatz, K., Waskow, C., Wiedemann, A., Wilharm, A., Wing, J., Wirz, O., Wittner, J., Yang, J. H. M., & Yang, J.
- Affiliations
- University of Modena and Reggio Emilia (IT)
- German Rheumatism Research Centre (DE)
- University of Milan (IT)
- Swiss Institute of Allergy and Asthma Research (SIAF) University of Zurich Davos Switzerland
- Technical University of Munich (DE)
- IRCCS Ospedale San Raffaele (IT)
- University of Florence (IT)
- Universidad de Valladolid (ES)
- Institute of Immunology Christian‐Albrechts Universität zu Kiel & Universitätsklinik Schleswig‐Holstein Kiel Germany
- National University of Singapore (SG)
- Italian Institute of Technology (IT)
- Medizinische Hochschule Hannover (DE)
- University of Bonn (DE)
- Division of Immunology Transplantation and Infectious Diseases IRCSS San Raffaele Scientific Institute Milan Italy
- University of British Columbia (CA)
- Monash University (AU)
- Humboldt-Universität zu Berlin (DE)
- Columbia University (US)
- German Center for Infection Research (DE)
- The University of Melbourne (AU)
- Sapienza University of Rome (IT)
- Institute for Research in Biomedicine (CH)
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- King's College London (GB)
- Helmholtz Centre for Infection Research (DE)
- Department of Medical and Surgical Sciences for Children & Adults University of Modena and Reggio Emilia Modena Italy
- Laboratory of Translational Immunology IRCCS Humanitas Research Hospital Rozzano Milan Italy
- IRCCS, Istituto Giannina Gaslini Genova Italy
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Institute of Molecular Biology and Pathology National Research Council of Italy (CNR) Rome Italy
- Innate Immunity Unit Department of Immunology Institut Pasteur Paris France
- Leibniz Association (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Inserm (FR)
- Agency for Science, Technology and Research (SG)
- University of Regensburg (DE)
- Hôpital Necker-Enfants Malades (FR)
- Mucosal Immunology Lab Unidad de Excelencia Instituto de Biomedicina y Genética Molecular de Valladolid (IBGM Universidad de Valladolid‐CSIC) Valladolid Spain
- University of Freiburg (DE)
- Nottingham Trent University (GB)
- Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) (DE)
- IRCCS Humanitas Research Hospital (IT)
- The Netherlands Cancer Institute (NL)
- Istituto Nazionale Genetica Molecolare (IT)
- University of Zurich (CH)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Hudson Institute of Medical Research (AU)
- University Hospital Schleswig-Holstein (DE)
- Friedrich‐Alexander‐University Erlangen‐Nürnberg (FAU) Department of Medicine 3 – Rheumatology and Immunology and Universitätsklinikum Erlangen Erlangen Germany
- Laboratory of Innate Immunity Department of Microbiology Infectious Diseases and Immunology Charité – Universitätsmedizin Berlin Campus Benjamin Franklin Berlin Germany
- Institut für Immunologie (DE)
- Heidelberg University (DE)
- Vita-Salute San Raffaele University (IT)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- German Rheumatism Research Center Berlin (DRFZ) Berlin Germany
- Otto-von-Guericke-Universität Magdeburg (DE)
- Universitätsklinikum Erlangen (DE)
- Leiden University Medical Center (NL)
- Goethe University Frankfurt (DE)
- ETH Zurich (CH)
- University of Birmingham (GB)
- University College London (GB)
- Fred Hutch Cancer Center (US)
- University of Lübeck (DE)
- Leipzig University (DE)
- The Francis Crick Institute (GB)
- Bambino Gesù Children's Hospital (IT)
- TUM Klinikum (DE)
- Institute of Molecular Biology and Pathology (IT)
- Immunology of Aging Leibniz Institute on Aging – Fritz Lipmann Institute Jena Germany
- Christian-Albrechts-Universität zu Kiel (DE)
- Immunology Frontier Research Center, The University of Osaka (JP)
- University Hospital Bonn (DE)
- Sanquin (NL)
- Institute for Medical Informatics Statistics and Epidemiology (IMISE) University of Leipzig Leipzig Germany
- Sanquin Research – Adaptive Immunity Amsterdam The Netherlands
- Infection and Immunity Program Department of Biochemistry and Molecular Biology Biomedicine Discovery Institute Monash University Clayton Victoria Australia
- Stanford Medicine (US)
- Corresponding author
- Cossarizza, Andrea
- Chang, Hyun‐Dong
- ORCID
- Cossarizza, Andrea
- Chang, Hyun‐Dong
- Radbruch, Andreas
- Abrignani, Sergio
- Addo, Richard
- Andrä, Immanuel
- Andreata, Francesco
- Annunziato, Francesco
- Arranz, Eduardo
- Bari, Sudipto
- Barnaba, Vincenzo
- Barros‐Martins, Joana
- Baumjohann, Dirk
- Bernardo, David
- Boardman, Dominic A.
- Borger, Jessica
- Böttcher, Chotima
- Brockmann, Leonie
- Busch, Dirk H.
- Cameron, Garth
- Cassotta, Antonino
- Chang, Yinshui
- Chirdo, Fernando Gabriel
- Čičin‐Šain, Luka
- Cook, Laura
- Corbett, Alexandra J.
- Cornelis, Rebecca
- Cosmi, Lorenzo
- Davey, Martin S.
- Delacher, Michael
- Diefenbach, Andreas
- Dong, Jun
- Dörner, Thomas
- Dress, Regine J.
- Dutertre, Charles‐Antoine
- Eckle, Sidonia B. G.
- Eede, Pascale
- Evrard, Maximilien
- Falk, Christine S.
- Feuerer, Markus
- Fillatreau, Simon
- Follo, Marie
- Foulds, Gemma A.
- Fröbel, Julia
- Gagliani, Nicola
- Galletti, Giovanni
- Gangaev, Anastasia
- Garbi, Natalio
- Garrote, José Antonio
- Geginat, Jens
- Gherardin, Nicholas A.
- Gibellini, Lara
- Ginhoux, Florent
- Godfrey, Dale I.
- Haftmann, Claudia
- Hansmann, Leo
- Harpur, Christopher M.
- Hayday, Adrian C.
- Heine, Guido
- Huang, Qing
- Huber, Samuel
- Huber, Johanna E.
- Huehn, Jochen
- Hundemer, Michael
- Hwang, William Y. K.
- Iannacone, Matteo
- Jäck, Hans‐Martin
- Keller, Baerbel
- Kessler, Nina
- Ketelaars, Steven
- Knop, Laura
- Knopf, Jasmin
- Koay, Hui‐Fern
- Kobow, Katja
- Kriegsmann, Katharina
- Kristyanto, H.
- Krueger, Andreas
- Kunze‐Schumacher, Heike
- Kvistborg, Pia
- Kwok, Immanuel
- Latorre, Daniela
- Levings, Megan K.
- Lino, Andreia C.
- Liotta, Francesco
- Long, Heather M.
- Lugli, Enrico
- MacDonald, Katherine N.
- Maggi, Laura
- Maini, Mala K.
- Mair, Florian
- Manta, Calin
- Manz, Rudolf Armin
- Mashreghi, Mir‐Farzin
- Mazzoni, Alessio
- McCluskey, James
- Mei, Henrik E.
- Mielenz, Dirk
- Monin, Leticia
- Moretta, Lorenzo
- Multhoff, Gabriele
- Muñoz‐Ruiz, Miguel
- Muscate, Franziska
- Natalini, Ambra
- Neumann, Katrin
- Ng, Lai Guan
- Almeida, Larissa Nogueira
- Notarbartolo, Samuele
- Ostendorf, Lennard
- Pallett, Laura J.
- Patel, Amit A.
- Peruzzi, Giovanna
- Pinti, Marcello
- Pockley, A. Graham
- Pracht, Katharina
- Prinz, Immo
- Pujol‐Autonell, Irma
- Pulvirenti, Nadia
- Quatrini, Linda
- Quinn, Kylie M.
- Radbruch, Helena
- Rhys, Hefin
- Rodrigo, Maria B.
- Romagnani, Chiara
- Sakaguchi, Shimon
- Sallusto, Federica
- Sanderink, Lieke
- Sandrock, Inga
- Scheffold, Alexander
- Scherer, Hans U.
- Schiemann, Matthias
- Schildberg, Frank A.
- Schober, Kilian
- Schoen, Janina
- Schuh, Wolfgang
- Schüler, Thomas
- Schulz, Axel R.
- Schulz, Sebastian
- Schulze, Julia
- Simonetti, Sonia
- Singh, Jeeshan
- Sitnik, Katarzyna M.
- Stark, Regina
- Starossom, Sarah
- Stehle, Christina
- Szelinski, Franziska
- Tan, Leonard
- Tree, Timothy I. M.
- Vasco, Chiara
- Verheyden, Nikita A.
- Ward‐Hartstonge, Kirsten A.
- Warnatz, Klaus
- Waskow, Claudia
- Wiedemann, Annika
- Wing, James
- Wirz, Oliver
- Wittner, Jens
- Yang, Jennie H. M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2021-12
- Volume
- 51
- Issue
- 12
- Pages
- 2708-3145
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- PMC
- PMC11115438
- OpenAlex
- W4200079077
- Semantic Scholar
- 2fc9fef4962f3df93ad714d00dfa4cab57a73158
- Cited by
- 531
- References
- 1,707
- Citations by year
- 2026: 136 · 2025: 115 · 2024: 111 · 2023: 89 · 2022: 78 · 2021: 2
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- European Journal of Immunology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (acceptedVersion, cc-by)
- RMIT Research Repository (RMIT University Library) (acceptedVersion)
- DR-NTU (Nanyang Technological University) (acceptedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- UCL Discovery (University College London) (acceptedVersion)
- Figshare (acceptedVersion)
- Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) (acceptedVersion, other-oa)
- Fraunhofer-Publica (Fraunhofer-Gesellschaft) (acceptedVersion)
- Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) (acceptedVersion, cc-by)
- Leiden Repository (Leiden University) (acceptedVersion, cc-by)
- National University of Singapore (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by)
- Leiden Repository (Leiden University) (submittedVersion, cc-by)
- BOA (University of Milano-Bicocca) (submittedVersion, cc-by)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
- University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
- Florence Research (University of Florence) (submittedVersion, other-oa)
- Nottingham Trent University's Institutional Repository (Nottingham Trent Repository) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, other-oa)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion, other-oa)
- PUB – Publications at Bielefeld University (Bielefeld University) (submittedVersion, cc-by)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Common Library Network (Der Gemeinsame Bibliotheksverbund) (submittedVersion, other-oa)
- Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc-nd)
- ETH Zürich Research Collection (cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Wellcome Trust (214191/Z/18/Z)
- Francis Crick Institute (10729, 10006)
- Cancer Research UK (26603, 26813)
- Medical Research Council (MR/V040162/1)
- National Institute of Allergy and Infectious Diseases (R01AI148407)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Keywords
- flow cytometry, cell sorting, immune cell phenotypes, immune cell subsets, functional assays, clinical samples, autoimmune disease, tumor immunology, infectious diseases
- MeSH terms
- Animals, Autoimmune Diseases, Chronic Disease, Flow Cytometry, Humans, Infections, Neoplasms, Practice Guidelines as Topic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.